1. Inoue M., Nobukuni Y., Ando Y., Hirata M., Hirata E., Morino Y.
Interorgan metabolism of glutathione as the defense mechanism against oxidative stress
Dev Toxicol Environ Sci, 14, 51-60 (1986)

2. Inoue M., Okajima K., Itoh K., Ando Y., Watanabe N., Yasaka T., Nagase S., Morino Y.
Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients
Kidney Int, 2, 198-203 (1987)

3. Okada S., Hamasaki S., Deng I L., Midorikawa O., Ando Y., Inoue M.
Sex differences in ferric nitrilotriacetate -induced lipid peroxidation and nephrotoxicity in mice
Cell Struct Funct, 13, 699-700 (1988)

4. Ando Y., Akaike T., Inoue M., Horisawa Y., Yamada Y., Uekawa K., Fujise R., Araki S.
Deferoxamine mesylate inhibits bacterial growth in vivo
Hokkaido Igaku Zasshi, 63, 207-212 (1988)

5. Ogino T., Inoue M., Ando Y., Awai M., Maeda H., Morino Y.
Chemical modification of superoxide dismutase
Int J Pept Prot Res, 32, 153-159 (1988)

6. Akaike T., Suga M., Ando M., Ando Y., Araki S.
Streptococcus acidominimus infections in a human
Jpn J Med, 127, 317-320 (1988)

7. Ando Y., Inoue M., Hirota M., Morino Y., Araki S.
Effect of SOD dismutase derivative on brain edema induced by cold injury
Brain Res, 477, 286-291 (1989)

8. Ando Y., Ikegawa S., Miyazaki A., Inoue M., Morino Y., Araki S.
Fate of normal and variant prealbumin in the circulation of rats
Clin Chim Acta, 179, 205-206 (1989)

9. Ando Y., Inoue M., Utsumi T., Morino Y., Araki S.
Synthesis of acylated SOD derivatives which bind to the biomembrane lipid surface and dismutate extracellular superoxide radicals
FEBS Lett, 240, 216-220 (1989)

10. Hirota M., Inoue M., Ando Y., Hirayama K.
Inhibition of stress-induced gastric injury in the rat by glutathione
Gastroenterology, 97, 853-859 (1989)

11. Ando Y., Yi S., Inoue M., Ikegawa S., Miyazaki A., Araki S.
Peruturbation of glucose metabolism in patients with familial amyloidotic polyneuropathy
Ann Neurol, 24, 689 (1990)

12. Ando Y., Ikegawa S., Miyazaki A., Inoue M., Morino Y., Araki S.
Role of variant prealbumin in pathogenesis of familial amyloidotic polyneuropathy: Fate of normal and variant prealbumin in the circulation
Arch Biochem Biophys, 274, 87-93 (1990)

13. Hirota M., Inoue M., Ando Y., Morino Y.
Inhibition of stress-induced gastric mucosal injury by a long acting superoxide dismutase that circulates bound to albumin
Arch Biochem Biophys, 280, 269-273 (1990)

14. Ando E., Ando Y., Inoue M., Morino Y., Kamata R., Okamura R.
Inhibition of corneal inflammation by an acylated superoxide dismutase derivation
Invest Ophthalmol Vis Sci, 31, 1963-1967 (1990)

15. Ando Y., Inoue M., Araki S., Morino Y.
Inhibition of carrageenin-induced paw edema by superoxide dismutase derivative that circulates bound to albumin
BBA-Gen Subjects, 1073, 374-379 (1991)

16. Ando Y., Yi S., Nakagawa T., Ikegawa S., Hirota M., Miyazaki A., Araki S.
Disturbed metabolism of glucose and related hormones in familial amyloidotic polyneuropathy
J Auton Nerv Syst (改名後 Auton Neurosci-Basic), 35, 63-70 (1991)

17. Ando Y., Inoue M.
Photooxidative inactivation of ectoenzymes on epithelial cell membranes
Biomed Res, 13, 365-369 (1992)

18. Ando E., Ando Y., Maruoka S., Sakai Y., Watanabe S., Yamashita R., Araki S.
Ocular microangiopathy in familial amyloidotic polyneuropathy, type I
Graefee Arch Clin Exp Ophthalmol, 230, 1-5 (1992)

19. Ando Y., Araki S., Shimoda O., Kano T.
Role of autonomic nerve function in patients with familial amyloidotic polyneuropathy as analyzed by laser Doppler flowmetry, capsule hydrograph, and cardiographic R-R interval
Muscle Nerve, 15, 507-512 (1992)

20. Asahara K., Ando Y., Tanaka Y., Yi S., Yamashita T., Ando M.
Secondary hypoplastic anemia in patients with familial amyloidotic polyneuropathy
Acta Haematol, 90, 130-135 (1993)

21. Ando Y., Tanaka Y., Ueyama H., Sakashita N., Yonehara T., Higuchi K., Araki S.
Low plasma apolipoprotein AII Levels in human and mouse amyloidosis with mutant transthyretin (Met30) gene
Ann Neurol, 33, 101-103 (1993)

22. Ueyama H., Kumamoto T., Asahara K., Watanabe S., Ando Y., Mita S., Ando M.
Hereditary motor and sensory neuropathy type V with spinal cord atrophy on magnetic response imaging
Eur Neurol, 33, 399-400 (1993)

23. Ando Y., Ueyama H., Watanabe S., Miyaji M., Tanaka Y., Araki S., Ando M.
Early involvement of motor nerve dysfunction in atypical case with familial amyloidotic polyneuropathy (FAP) type I
Muscle Nerve, 16, 978-979 (1993)

24. Tanaka Y., Ando Y., Kumamoto T., Miyazaki A., Nakamura M., Nakayama M., Araki S., Ando M.
Changed affinity of apolipoprotein AII to high density lipoprotein (HDL) in patients with familial amyloidotic polyneuropathy (FAP) Type I
BBA-Mol Basis Dis, 1225, 311-316 (1994)

25. Sakashita N., Ando Y., Yonehara T., Tanaka Y., Sato K., Uchino M., Ando M.
Role of superoxide dismutase and nitric oxide on the interaction between brain and systemic circulation during brain ischemia
BBA-Gen Subjects, 1227, 67-73 (1994)

26. Ando Y., Yamashita T., Tanaka Y., Tashima K., Yonehara T., Sakashita N., Uchino M., Ando M.
Role of nitric oxide in the peripheral vessels of patients with familial amyloidotic polyneuropathy (FAP) type I
J Auton Nerv Syst (改名後 Autonom Neurosci-Basic), 50, 79-85 (1994)

27. Uchino M., Ando Y., Tanaka Y., Nakamura T., Uyama E., Mita S., Murakami T., Ando M.
Decrease in Cu/Zn- and Mn-superoxide dismutase activities in brain and spinal cord of patients with amyotrophic lateral sclerosis
J Neurol Sci, 127, 61-67 (1994)

28. Ando Y., Obayashi K., Tanaka Y., Tsuji A., Uchino M., Takahashi M., Ando M.
Radiolabelled meta-iodobenzylguanidine in assessment of autonomic dysfunction
Lancet, 343, 984-985 (1994)

29. Yonehara T., Ando Y., Kimura K., Uchino M., Ando M.
Detection of reverse flow by duplex ultrasonography in orthostatic hypotension
Stroke, 25, 2407-2411 (1994)

30. Ando Y., Tashima K., Tanaka Y., Ericzon B G., Nakazato M., Duraj F F., Yamashita T., Kimura E., Ando E., Yonehara T., Nakamura M., Uchino M., Ando M.
Treatment of a Japanese patient with familial amyloidotic polyneuropathy with orthotopic liver transplantation
Intern Med, 33, 730-732 (1994)

31. Ando Y., Obayashi K., Tanaka Y., Yamashita T., Uchino M., Tsuji A., Takahashi M., Ando M.
Radiolabelled meta-iodobenzylguanidine in assessment of autonomic dysfunction
Amyloid, 2, 183-187 (1995)

32. Ando Y., Tanaka Y., Nakazato M., Ericzon B G., Yamashita T., Tashima K., Sakashita N., Suga M., Uchino M., Ando M.
Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy Type I following liver transplantation
Biochem Bioph Res Commun, 211, 354-358 (1995)

33. Tashima K., Ando Y., Tanaka Y., Uchino M., Ando M.
Change in the age of onset in patients with familial amyloidotic polyneuropathy type I
Internal Med, 34, 748-750 (1995)

34. Uchino M., Tanaka Y., Ando Y., Yonehara T., Hara A., Mishima I., Okajima T., Ando M.
Neurologic features of chronic Minamata disease (Organic mercury poisoning) and incidence of complications with aging
J Environ Sci Health B, 30, 699-715 (1995)

35. Uchino M., Tokunaga M., Mita S., Uyama E., Ando Y., Teramoto H., Miike T., Ando M.
PCR and immunocytochemical analyses of dystrophin-positive fibers in Duchenne muscular dystrophy
J Neurol Sci, 129, 44-50 (1995)

36. Ando Y., Tanaka Y., Ando E., Yamashita T., Nishida Y., Tashima K., Suga M., Uchino M., Ando M.
Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I
Lancet, 345, 195-196 (1995)

37. Ando Y., Sato K., Sakashita N., Tanaka Y., Uchino M., Ando M.
Scavenging potential of azelastine against oxygen free radicals
Pharmaceut Pharmacol Lett, 1, 5-7 (1995)

38. Ando Y., Gotoh T., Kawaguchi Y., Tanaka Y., Sakashita N., Ando M.
Intranasal L-threo-3, 4 dihydroxyphenylserine (L-threo-DOPS) in treating diarrhea associated with familial amyloidotic polyneuropathy (FAP)
Pharmacotherapy, 15, 345-349 (1995)

39. Ando Y., Kai S., Uyama E., Iyonaga K., Hashimoto Y., Uchino M., Ando M.
Involvement of the central nervous system in rheumatoid arthritis: its clinical manifestations and analysis by magnetic resonance imaging
Internal Med, 34, 188-191 (1995)

40. Arima T., Ando Y., Ando E., Okamura R., Sakashita M., Uchino M., Ando M.
Secondary amyloidosis with severe autonomic dysfunctions
J Auton Nerv Syst (Auton Neurosci-Basic), 52, 77-81 (1995)

41. Ando Y., Fujii S., Sakashita N., Uchino M., Ando M.
Acquired idiopathic generalized anhidrosis: clinical manifestations and histochemical studies
J Neurol Sci, 132, 80-83 (1995)

42. Ando Y., Ando E., Uchino M., Ando M.
HTLV-1 associated pandysautonomia with adrenal dysfunction
Muscle Nerve, 18, 928-929 (1995)

43. Nakamura M., Tanaka Y., Ando Y., Yamashita T., Ferlini A., Salvi F., Uchino M., Ando M.
Decreased affinity of apolipoprotein AII to high density lipoprotein (HDL) in patients with transthyretin related amyloidosis (Met30, Gln89, Pro36, and Thr34)
Biochem Bioph Res Commun, 219, 316-321 (1996)

44. Ando Y., Ohlsson PI., Suhr O., Nyhlin N., Yamashita T., Holmgren G., Danielsson A., Sandgren O., Uchino M., Ando M.
A new simple and rapid screening method for variant transthyretin (TTR) related amyloidosis
Biochem Bioph Res Commun, 228, 480-483 (1996)

45. Uchino M., Hara A., Mizuno Y., Fujiki M., Nakamura T., Tokunaga M., Hirano T., Yamashita T., Uyama E., Ando Y., Mita S., Ando M.
Distribution of dystrophin and dystrophin-associated protein 43DAG (beta-dystroglycan) in the central nervous system of normal controls and patients with Duchenne muscular dystrophy
Internal Med, 35, 189-194 (1996)

46. Abe M., Ando Y., Higashi K., Kano T.
Non-neurogenic periodic fluctuations in heart rate and vasomotion appearing in familial amyloidotic polyneuropathy (FAP) Type I (Met30)
J Auton Nerv Syst (改名後 Autonom Neurosci-Basic), 60, 71-75 (1996)

47. Ando Y., Asahara K., Obayashi K., Suhr O., Yonemitsu M., Yamashita T., Tashima K., Uchino M., Ando M.
Autonomic dysfunction and anemia in neurologic disorders
J Auton Nerv Syst (改名後 Autonom Neurosci-Basic), 61, 145-148 (1996)

48. Ando Y., Suhr O., Tashima K., Yamashita T., Ando M.
What is genetic anticipation?
Lancet, 348, 331-332 (1996)

49. Ando Y., Yonehara T., Tanaka Y., Tashima K., Uchino M., Ando M.
Early pacemaker implantation in patients with familial amyloidotic polyneuropathy
Muscle Nerve, 19, 1640-1641 (1996)

50. Hirai T., Korogi Y., Hamatake S., Ikushima I., Shigematsu Y., Takahahsi M., Ando Y., Arima T., Ando M.
Case report: varicella-zoster virus myelitis--serial MR findings
Br J Radiol, 69, 1187-1190 (1996)

51. Ando Y., Yonemitsu M., Uchino M., Ando M.
Tonic pupil with orthostatic hypotension in childhood
Muscle Nerve, 19, 798-799 (1996)

52. Ando Y., Ando E., Tanaka Y., Yamashita T., Tashima K., Suga M., Uchino M., Negi A., Ando M.
De novo amyloid synthesis in the ocular tissue in familial amyloidotic polyneuropathy (FAP) after liver transplantation
Transplantation, 62, 1037-1038 (1996)

53. Kawano O., Kohrogi H., Ando Y., Iwagoe H., Fujii K., Hamamoto J., Yamaguchi T., Okabe H., Ando M.
Bronchial hyperreactivity in patients with familial amyloidotic polyneuropathy and autonomic neuropathy
Am J Resp Crit Care, 155, 1465-1468 (1997)

54. Tashima K., Ando Y., Tanaka Y., Ando E., Ando M., Uchino M.
Heterogeneity of clinical symptoms in patients with familial amyloidotic polyneuropathy (FAP) (Met30)
Amyloid, 4, 108-111 (1997)

55. Ando Y., Nyhlin N., Suhr O., Holmgren G., Uchida K., el-Salhy M., Yamashita T., Terasaki H., Nakamura M., Uchino M., Ando M.
Oxidative stress is found in amyloid deposits in systemic amyloidosis
Biochem Bioph Res Commun, 232, 497-502 (1997)

56. Yamashita T., Ando Y., Sakashita N., Hirayama K., Tanaka Y., Tashima K., Uchino M., Ando M.
Role of nitric oxide in the cerebellar degeneration during methylmercury intoxication
BBA-Gen Subjects, 1334, 303-311 (1997)

57. Ando E., Ando Y., Okamura R., Uchino M., Ando M., Negi A.
Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up
Br J Ophthalmol, 81, 295-298 (1997)

58. Suhr OB., Wiklund U., Ando Y., Ando E., Olofsson BO.
Impact of liver transplantation on autonomic neuropathy in familial amyloidotic polyneuropathy : an evaluation by spectral analysis of heart rate variability
J Intern Med, 242, 225-229 (1997)

59. Suhr OB., Wiklund U., Eleborg L., Ando Y., Backman C., Birgersdotter V., Bjerle P., Ericzon B G., Johansson B., Olofsson BO.
Impact on autonomic neuropathy on circulatory instability during liver transplantation for familial amyloidotic polyneuropathy
Transplantation, 63, 675-679 (1997)

60. Ando Y., Yamashita T., Nakamura M., Tanaka Y., Hashimoto M., Tashima K., Suhr O., Uemura Y., Obayashi K., Terasaki H., Suga M., Uchino M., Ando M.
Down regulation of a harmful variant protein by replacement of its normal protein
Biochim Biophys Acta, 1362, 39-46 (1997)

61. Ranlov I., Ando Y., Ohlsson PI., Holmgren G., Ranlov P J., Suhr OB.
Rapid screening for amyloid-related variant forms of transthyretin is possible by electrospray ionization mass spectrometry
Eur J Clin Invest, 27, 956-959 (1997)

62. Yamashita T., Ando Y., Obayashi K., Uchino M., Ando M.
Change in nitrite and nitrate (No2-/No3-) levels in cerebrospinal fluid of patients with multiple screlosis
J Neurol Sci, 153, 32-34 (1997)

63. Fujimoto H., Ando Y., Yamashita T., Terazaki H., Tanaka Y., Sasaki J., Matsumoto M., Suga M., Ando M.
Nitric oxide synthase (NOS) activity in human lung cancer
Jpn J Cancer Res, 88, 1190-1198 (1997)

64. Ando Y., Suhr O., Yamashita T., Ohlsson PI., Holmgren G., Obayashi K., Terazaki H., Uchino M., Ando M.
Detection of different forms of variant transthyretin (Met30) in cerebrospinal fluid
Neurosci Lett, 238, 123-126 (1997)

65. Takahashi K., Sakashita N., Ando Y., Suga M., Ando M.
Late onset type I familial amyloidotic polyneuropathy: presentation of three autopsy cases in comparison with 19 autopsy cases of the ordinary type
Pathol Int, 47, 353-359 (1997)

66. Holmgren G., Ando Y., Wikstrom L., Rydh A., Suhr O.
Discordant symptoms in monozygotic twins with familial amyloidotic polyneuropathy (FAP) (TTR met30)
Amyloid, 4, 178-180 (1997)

67. Ando Y., Ericzon B. G., Suhr O., Tashima K., Ando M.
Reuse of a Japanese familial amyloidotic polyneuropathy patient's liver for a cancer patient: the domino liver transplantation procedure
Internal Med, 36, 847 (1997)

68. Shiraishi N, Ando Y., Mizuta H., Nakamura E., Takagi K., Ando M.
Charcot knee arthropathy with articular amyloid deposition in familial amyloidotic polyneuropathy
Scand J Rheumatol, 26, 61-64 (1997)

69. Terazaki H., Ando Y., Suhr O., Ohlsson PI., Obayashi K., Yamashita T., Yoshimatsu S., Suga M., Uchino M., Ando M.
Post-translational modification of transthyretin in plasma
Biochem Bioph Res Commun, 249, 26-30 (1998)

70. Ando Y., Anan I., Suhr O., Holmgren G., Costa PM.
Detection of a variant protein in hair: new diagnostic method in Portuguese type familial amyloid polyneuropathy
Brit Med J, 316, 1500-1501 (1998)

71. Suhr OB., Ando Y., Olsson P I., Olofsson A., Andersson K., Lundgren E., Ando M., Holmgren G.
Investigation into thiol conjugation of transthyretin in hereditary transthyretin amyloidosis
Eur J Clin Invest, 28, 687-692 (1998)

72. Terazaki H., Ando Y., Yamashita T., Obayashi K., Nakamura K., Yoshimatsu S., Suga M., Uchino M., Ando M.
Visceral orthostatic hypotension in patients with severe autonomic dysfunction
J Auton Nerv Syst (改名後 Autonom Neurosci-Basic), 68, 101-108 (1998)

73. Yoshimatsu S., Ando Y., Terazaki H., Sakashita N., Tada S., Yamashita T., Suga M., Uchino M., Ando M.
Endoscopic and pathological manifestations of the gastrointestinal tract in familial amyloidotic polyneuropathy (FAP) Type I (Met30)
J Intern Med, 243, 65-72 (1998)

74. Ando Y., Brannstrom T., Uchida K., Nyhlin N., Nasman B., Suhr O., Yamashita T., Olsson T., Uchino M., Ando M.
Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid
J Neurol Sci, 156, 172-176 (1998)

75. Fujimoto H., Sasaki J., Matsumoto M., Suga M., Ando Y., Iggo R., Tada M., Saya H., Ando M.
Significant correlation of nitric oxide synthase activity and p53 gene mutation in stage I lung adenocarcinoma
Jpn J Cancer Res, 89, 696-702 (1998)

76. Fowler C J., Ando Y., Tiger G.
Comparison of hydrogen peroxide, 4-hydroxy-2-nonenal and β-amyloid (25-35) upon calcium signaling
Neurochem Int, 33, 161-172 (1998)

77. Ohnishi A., Yamamoto T., Murai Y., Ando Y., Ando M., Hoshii Y., Ikeda M.
Denervation of eccrine glands in patients with familial amyloidotic polyneuropathy type I
Neurology, 51, 714-721 (1998)

78. Suhr OB., Holmgren G., Ando Y.
Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation
Neurology, 51, 926-927 (1998)

79. Suhr O., Ando Y., Holmgren G., Wikstrom L., Friman S., Ericzon BG.
Liver transplantation in familial amyloidotic polyneuropathy (FAP). A comparative study of transplanted and non-transplanted patient's survival
Transplant Int, 11, S160-S163 (1998)

80. Sakashita N., Ando Y., Marklund S. L., Nilsson P., Tashima K., Yamashita T., Takahashi K.
Familial amyloidotic polyneuropathy Type I with extracellular superoxide dismutase mutation: A case report
Hum Pathol, 29, 1169-1172 (1998)

81. Anan I., el-Salhy M., Ando Y., Forsgren S., Nihlin N., Terazaki H., Sakashita N., Suhr OB.
Colonic enteric nervous system in patients with familial amyloidotic neuropathy
Acta Neuropathol (Berl), 98, 48-54 (1999)

82. Ando Y., Ando E., Ohlsson PI., Olofsson A., Sandgren O., Suhr O., Terazaki H., Obayashi K., Lundgren E., Ando M., Negi A.
Analysis of transthyretin amyloid fibrils from vitreous samples in familial amyloidotic polyneuropathy (Val30Met)
Amyloid, 6, 119-123 (1999)

83. Tashima K., Suhr OB., Ando Y., Holmgren G., Yamashita T., Obayashi K., Terazaki H., Uchino M.
Gastrointestinal dysfunction in familial amyloidotic polyneuropathy (ATTR Val30Met) -comparison of Swedish and Japanese patients
Amyloid, 6, 124-129 (1999)

84. Suhr OB., Svendsen I H., Ohlsson PI., Lendoire J., Trigo P., Tashima K., Ranlov PJ., Ando Y.
Impact of age and amyloidosis on thiol conjugation of transthyretin in hereditary transthyretin amyloidosis
Amyloid, 6, 187-191 (1999)

85. Nyhlin N., Anan I., el-Salhy M., Ando Y., Suhr OB.
Endocrine cells in the upper gastrointestinal tract in relation to gastrointestinal dysfunction in patients with familial amyloidotic polyneuropathy
Amyloid, 6, 192-198 (1999)

86. Lendoire JC., Trigo P., Aziz H., Cueto G., Ando Y., Ohlsson PI., Suhr OB., Imventarza O.
Liver transplantation in transthyretin familial amyloid polyneuropathy: first report from Argentina
Amyloid, 6, 297-300 (1999)

87. Ando Y., Almeida MR., Ohlsson PI., Ando E., Negi A., Suhr O., Terazaki H., Obayashi K., Ando M., Saraiva MJ.
Unusual self-association properties of transthyretin Y114C related to familial amyloidotic polyneuropathy: effects on detection and quantification
Biochem Bioph Res Commun, 261, 264-269 (1999)

88. Terazaki H., Ando Y., Misumi S., Nakamura M., Ando E., Matsunaga N., Shoji S., Okuyama M., Ideta H., Nakagawa K., Ishizaki T., Ando M. & Saraiva MJ.
A novel compound heterozygote (FAP ATTR Arg104His/ATTR Val30Met) with high serum transthyretin (TTR) and retinol binding protein (RBP) levels
Biochem Bioph Res Commun, 264, 365-370 (1999)

89. Misu K., Hattori N., Nagamatsu M., Ikeda S., Ando Y., Nakazato M., Takei Y., Hanyu N., Usui Y., Yanaka F., Harada T., Inukai A., Hashizume Y., Sobue G.
Late-onset familial amyloiudotic polyneuropathy type I (Met30 transthyretin mutation) unrelated to endemic focus in Japan: Clinicopathologic and genetic features
Brain, 122, 1951-1962 (1999)

90. Nakamura M., Yamashita T., Ando Y., Asl KH., Tashima K., Ohlsson PI., Kususe Y., Wang L., Benson M.D.
Identification of a new transthyretin variant (ILe49) in familial amyloidotic polyneuropathy using electrospray ionization mass spectrometry and Non-Isotopic RNase Cleavage Assay
Hum Hered, 49, 186-189 (1999)

91. Anan I., el-Salhy M., Ando Y., Nihlin N., Terazaki H., Sakashita N., Suhr OB.
Colonic endocrine cells in patients with familial amyloidotic polyneuropathy
J Intern Med, 245, 469-473 (1999)

92. Tashima K., Ando Y., Terazaki H., Yoshimatsu S., Suhr OB., Obayashi K., Yamashita T., Ando E., Uchino M., Ando M.
Outcome of liver transplantation for transthyretin amyloidosis: follow-up of Japanese familial amyloidotic polyneuropathy patients
J Neurol Sci, 171, 19-23 (1999)

93. Lendoire JC., Trigo P., Aziz H., Romero MC., Inventarza O., Ando Y., Tashima K., Ohlsson PI., Cederquist K., Holmgren G., Suhr OB.
Variant transthyretin (TTR) amyloidosis in Argentina. Detection of the trait by electrospray ionization mass spectrometry of lyophilized TTR immunoprecipitate
Scand J Clin Lab Invest, 59, 613-618 (1999)

94. Ando Y., Ohtsu Y., Terazaki H., Kibayashi K., Nakamura M., Ando E., Matsunaga N., Obayashi K., Uchino M., Ando M., Tsunenari S.
Japanese monozygotic twins with familial amyloidotic polyneuropathy (FAP) (ATTR Val30Met)
Amyloid, 7, 133-136 (2000)

95. Obayashi K., Ando Y., Terazaki H., Yamashita T., Nakamura M., Suga M., Uchino M., Ando M.
Mechanism of anemia associated with autonomic dysfunction in rats
Auton Neurosci-basic, 82, 123-129 (2000)

96. Almeida MR., Alves IL., Terazaki H., Ando Y., Saraiva M J.
Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M
Biochem Bioph Res Commun, 270, 1024-1028 (2000)

97. Mambule C., Ando Y., Anan I., Holmgren G., Sandgren O., Stigbrandt T., Tashima K., Suhr OB.
Enhancement of AA-amyloid formation in mice by transthyretin amyloid fragments and polyethylene glycol
BBA-Mol Basis Dis, 1474, 331-336 (2000)

98. Obayashi K., Ando Y., Terazaki H., Yamashita S., Nakagawa K., Nakamura M., Yamashita T., Suga M., Ishizaki T., Uchino M., Ando M.
Effect of sildenafil citrate (Viagra) on erectile dysfunction in a patient with familial amyloidotic polyneuropathy ATTR Val30Met
J Auton Nerv Syst (改名後 Auton Neurosci-Basic), 80, 89-92 (2000)

99. Katsuragi S., Miyakawa T., Ando Y., Terazaki H.
High-resolution ultrastructure of amyloid fibrils in familial amyloid polyneuropathy
J Electron Microsc (Tokyo), 49, 579-581 (2000)

100. Nyhlin N., Ando Y., Nagai R., Suhr O., el-Salhy M., Terazaki H., Yamashita T., Ando M., Horiuchi S.
Advanced glycation end product in familial amyloidotic polyneuropathy (FAP)
J Intern Med, 247, 485-492 (2000)

101. Yamashita T., Ando Y., Suhr OB., Nakamura M., Sakashita N., Ohlsson PI., Terazaki H., Obayashi K., Uchino M., Ando M.
A new diagnostic procedure to detect unknown transthyretin (TTR) mutations in familial amyloidotic polyneuropathy (FAP)
J Neurol Sci, 173, 154-159 (2000)

102. Yamashita T., Ando Y., Obayashi K., Terazaki H., Sakashita N., Uchida K., Ohama E., Ando M., Uchino M.
Oxidative injury is present in Purkinje cells in patients with olivopontocerebellar atrophy
J Neurol Sci, 175, 107-110 (2000)

103. Obayashi K., Ando Y., Nakamura M., Terazaki H., Yamashita T., Tashima K., Suga M., Uchino M., Ando M.
Endothelium-dependent vasodilatation in patients with familial amyloidotic polyneuropathy
Muscle Nerve, 23, 1084-1088 (2000)

104. Misu K., Hattori N., Ando Y., Ikeda S., Sobue G.
Anticipation in early- but not late-onset familial amyloid polyneuropathy (TTR Met 30) in Japan
Neurology, 55, 451-452 (2000)

105. Nishizaki T., Kishikawa K., Yoshizumi T., Uchiyama H., Okano S., Ikegami T., Hashimoto K., Nomoto K., Shimada M., Yanaga K., Takenaka K., Sugimachi K., Ando Y., Ando M.
Domino liver transplantation from a living related donor
Transplantation, 70, 1236-1239 (2000)

106. Sakashita N., Ando Y., Obayashi K., Terazaki H., Yamashita T., Takeya M., Kinjo M., Takahashi K.
Familial amyloidotic polyneuropathy (ATTR Ser50Ile): the first autopsy case report
Virchows Arch, 436, 345-350 (2000)

107. Anan I., el-Salhy M., Ando Y., Terazaki H., Suhr OB.
Comparison of amyloid deposits and infiltration of enteric nervous system in the upper with those in the lower gastrointestinal tract in patients with familial amyloidotic polyneuropathy
Acta Neuropathol (Berl), 102, 227-232 (2001)

108. Sakashita N., Ando Y., Jinnouchi K., Yoshimatsu M., Terazaki H., Obayashi K., Takeya M.
Familial amyloidotic polyneuropathy (ATTR Val30Met) with widespread cerebral amyloid angiopathy and lethal cerebral hemorrhage
Pathol Int, 51, 476-480 (2001)

109. Suhr OB., Lang K., Wikstrom L., Anan I, Ando Y., el-Salhy M., Holmgren G., Tashima K.
Scavenger treatment of free radical injury in familial amyloidotic polyneuropathy: a study on Swedish transplanted and non-transplanted patients
Scand J Clin Lab Invest, 61, 11-18 (2001)

110. Uchino M., Mita S., Satoh H., Hirano T., Arimura K., Nakagawa M., Nakamura M., Uyama E., Ando Y., Wakamiya J., Futatsuka M.
Clinical investigation of the lesions responsible for sensory disturbance in Minamata disease
Tohoku J Exp Med, 195, 181-189 (2001)

111. Terazaki H., Ando Y., Nakamura M., Obayashi K., Misumi S., Shoji S., Yamashita S., Nakagawa K., Ishizaki T., Suhr O, Uemoto S, Inomata Y., Tanaka K.
Variant transthyretin in blood circulation can transverse the blood-cerebrospinal barrier: qualitative analyses of transthyretin metabolism in sequential liver transplantation
Transplantation, 72, 296-299 (2001)

112. Ogawa H., Mizuno Y., Ohkawara S., Tsujita K., Ando Y., Yoshinaga M., Yasue H.
Cardiac amyloidosis presenting as microvascular angina--a case report
Angiology, 52, 273-278 (2001)

113. Ando E., Ando Y., Haraoka K.
Ocular amyloid imvolvement after liver transplantation for polyneuropathy
Ann Intern Med, 135, 931-932 (2001)

114. Yoshioka A., Yamaya Y., Saiki S., Hirose G., Shimazaki K., Nakamura M., Ando Y.
A case of familial amyloid polyneuropathy homozygous for the transthyretin Val30Met gene with motor-dominant sensorimotor polyneuropathy and unusual sural nerve pathological findings
Arch Neurol, 58, 1914-1918 (2001)

115. Watanabe M., Yamashita T., Hara A., Murakami T., Ando Y., Uyama E., Mita S., Uchino M.
High signal in the spinal cord on T2-weighted images in rapidly progressive tropical spastic paraparesis
Neuroradiology, 43, 231-233 (2001)

116. Matsunaga N., Anan I., Forsgren S., Nagai R., Rosenberg P., Horiuchi S., Ando Y., Suhr OB.
Advanced glycation end products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce NF-kappaB activation
Acta Neuropathol (Berl), 104, 441-447 (2002)

117. Haraoka K., Ando Y., Ando E., Sandgren O., Nakamura M., Tajiri T., Tanoue Y., Sun X., Okabe H., Tanihara H.
Amyloid deposition in ocular tissues of patients with familial amyloidotic polyneuropathy (FAP)
Amyloid, 9, 183-189 (2002)

118. Haraoka K., Ando Y., Ando E., Sun X., Terazaki H., Musumi S., Tanoue Y., Nakamura M., Tajiri T., Shoji S., Ishizaki T., Okabe H., Tanihara H.
Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation
Amyloid, 9, 247-251 (2002)

119. Koike H., Misu K., Ikeda S., Ando Y., Nakazato M., Ando E., Yamamoto M., Hattori N., Sobue G.
Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form
Arch Neurol, 59, 1771-1776 (2002)

120. Eneqvist T., Olofsson A., Ando Y., Miyakawa T., Katsuragi S., Jass J., Lundgren E., Sauer-Eriksson AE.
Disulfide-bond formation in the transthyretin mutant Y114C prevents amyloid fibril formation in vivo and in vitro
Biochemistry, 41, 13143-13151 (2002)

121. Tajiri T., Ando Y., Hata K., Kamide K., Hashimoto M., Nakamura M., Terazaki H., Yamashita T., Kai H., Haraoka K., Imasato A., Takechi K., Nakagawa K., Okabe H., Ishizaki T.
Amyloid formation in rat transthyretin: effect of oxidative stress
Clin Chim Acta, 323, 129-137 (2002)

122. Nyhlin N., Anan I., el-Salhy M., Ando Y., Suhr OB.
Reduction of free radical activity in amyloid deposits following liver transplantation for familial amyloidotic polyneuropathy
J Intern Med, 251, 136-141 (2002)

123. Niraula T N., Haraoka K., Ando Y., Li H., Yamada H., Akasaka K. *(Double correspondence)
Decreased thermodynamic stability as a crucial factor for familial amyloidotic polyneuropathy
J Mol Biol, 320, 333-342 (2002)

124. Watanabe H., Misu K., Kobayashi T., Hattori N., Doyu M., Yokoyama I., Ando Y., Nakao A., Sobue G.
ABO-incompatible auxiliary partial orthotopic liver transplant for late-onset familial amyloid polyneuropathy
J Neurol Sci, 195, 63-66 (2002)

125. Ando Y., Nakamura M., Kai H., Katsuragi S., Terazaki H., Nozawa T., Okuda T., Misumi S., Matsunaga N., Tajiri T., Shoji S., Yamashita T., Haraoka K., Obayashi K., Matsumoto K., Ando M., Uchino M.
A novel localized amyloidosis associated with lactoferrin in the cornea
Lab Invest, 82, 757-766 (2002)

126. Ando Y., Terazaki H., Haraoka K., Tajiri T., Nakamura M., Obayashi K., Misumi S., Shoji S., Hata K., Nakagawa K., Ishizaki T., Uemoto S., Inomata Y., Tanaka K., Okabe H.
Presence of autoantibody against ATTR Val30Met after sequential liver transplantation
Transplantation, 73, 751-755 (2002)

127. Koga T., Ando E., Hirata A., Fukushima M., Kimura A., Ando Y., Negi A., Tanihara H.
Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy
Am J Ophthalmol, 135, 188-193 (2003)

128. Kimura A., Ando E., Fukushima M., Koga T., Hirata A., Arimura K., Ando Y., Negi A., Tanihara H.
Secondary glaucoma in patients with familial amyloidotic polyneuropathy
Arch Ophthalmol, 121, 351-356 (2003)

129. Sun X., Ando Y., Haraoka K., Katsuragi S., Yamashita T., Yamashita S., Okajima M., Terazaki H., Okabe H.
Role of VLDL/chylomicron in amyloid formation in familial amyloidotic polyneuropathy
Biochem Bioph Res Commun, 311, 344-350 (2003)

130. Cuajungco MP., Ando Y., Axelrod FB., Biaggioni I., Goldstein DS., Guttmacher AE., Gwinn-Hardy K., Hahn MK., Hilz MJ., Jacob G., Jens J., Kennedy WR., Liggett SB., O’Connor D., Peltzer SR., Robertson D., Rubin BY., Scudder Q., Smith LJ., Sonenshein GE., Svejstrup JQ., Xu Y., Slaugenhaupt A.
Hereditary dysautonomias: current knowledge and collaborations for the future
Clin Auton Res, 13, 180-195 (2003)

131. Motomiya Y., Ando Y., Haraoka K., Sun X., Iwamoto H., Uchimura T., Maruyama I.
Circulating level of alpha2-macroglobulin-beta2-microglobulin complex in hemodialysis patients
Kidney Int, 64, 2244-2252 (2003)

132. Ando Y., Haraoka K., Terazaki H., Tanoue Y., Ishikawa K., Katsuragi S., Nakamura M., Sun X., Nakagawa K., Ishizaki T., Takesako K., Sasaki Y., Doh-ura K.
A novel tool for detecting amyloid deposits in systemic amyloidosis in vitro and in vivo
Lab Invest, 83, 1751-1759 (2003)

133. Nakamura M., Ando Y., Nagahara S., Sano A., Ochiya T., Maeda S., Kawaji T., Ogawa M., Hirata A., Terazaki H., Haraoka K., Tanihara H., Uchino M., Yamamura K.
Targeted conversion of the transthyretin gene in vitro and in vivo
Gene Ther, 11, 838-846 (2004)

134. Ohmori H., Ando Y., Makita Y., Onouchi Y., Nakajima T., Saraiva M J M., Terazaki H., Suhr O., Sobue G., Nakamura M., Yamaizumi M., Munar-Ques M., Inoue I., Uchino M., Hata A.
Common origin of the Val30Met mutation responsible for the amyloidogenic transthyretin type of familial amyloidotic polyneuropathy
J Med Genet, 41, e51-e55 (2004)

135. Koike H., Misu K., Sugiura M., Iijima M., Mori K., Yamamoto M., Hattori N., Mukai E., Ando Y., Ikeda S., Sobue G.
Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy
Neurology, 63, 129-138 (2004)

136. Obayashi K., Ando Y., Nakamura M., Yamashita T., Ueda M., Haraoka K., Terazaki H., Uchino M.
Near-infrared spectrophotoscopy in assessment of autonomic dysfunction - As a useful marker of autonomic dysfunction -
Neurology, 63, 164-166 (2004)

137. Ando Y., Terazaki H., Nakamura M., Ando E., Haraoka K., Yamashita T., Ueda M., Okabe H., Sasaki Y., Tanihara H., Uchino M., Inomata Y.
A different amyloid formation mechanism: De novo oculoleptomeningeal amyloid deposits after liver transplantation
Transplantation, 77, 345-349 (2004)

138. Ishikawa K., Doh-ura K., Kudo Y., Nishida N., Murakami-Kubo I., Ando Y., Sawada T., Iwaki T.
Amyloid imaging probes are useful for detection of prion plaques and treatment of transmissible spongiform encephalopathies
J Gen Virol, 85, 1785-1790 (2004)

139. Yamashita T., Ando Y., Nakamura M., Obayashi K., Terazaki H., Haraoka K., Sun X., Ueda M., Uchino M.
Inhibitory effect of α-tocopherol on methylmercury-induced oxidative stress
Environ Health Prev Med, 9, 111-117 (2004)

140. Kitajima M., Horogi Y., Yamura K., Ikushima I., Hayashida Y., Ando Y., Uchino M., Yamashita Y.
Familial amyloid polyneuropathy: Hypertrophy of ligaments supporting the spinal cord
Am J Neuroradiol, 25, 1599-1602 (2004)

141. Yamashita T., Ando Y., Katsuragi S., Nakamura M., Obayashi K., Haraoka K., Ueda M., Uchino M.
Familial amyloid angiopathy with muscular amyloid angiopathy
Muscle Nerve, 31, 41-45 (2004)

142. Obayashi K., Hanyu O., Miida T., Ando Y., Nakamura M., Zhu Y., Okada M.
Circadian rhythm of protein C in human plasma: Useful marker of autonomic function in liver
Clin Auton Res, 15, 57-58 (2004)

143. Kawaji T., Ando Y., Ando E., Nakamura M., Hirata K., Tanihara H.
A case of vitreous amyloidosis without systemic symptoms in familial amyloidotic Polyneuropathy.
Amyloid, 11, 257-259 (2004)

144. Motomiya Y., Ando Y., Haraoka K., Sun X., Morita H., Amano I., Uchimura T., Maruyama I.
Studies on unfolded beta2-microglobulin at C-terminal in dialysis related amyloidosis
Kidney Int, 67, 314-320 (2005)

145. Araki-Sasaki K., Ando Y., Nakamura M., Kitagawa K., Ikemizu S., Kawaji T., Yamashita T., Ueda M., Hirano K., Yamada M., Matsumoto K., Kinoshita S., Tanihara H.
Lactoferrin Glu561Asp facilitates amyloid formation in the cornea
Brit J Ophthal, 89, 684-648 (2005)

146. Sugiuchi H., Ando Y., Manabe M., Nakamura E., Mizuta H., Nagata S., Okabe H.
Measurement of total and differential white blood cell counts in synovial fluid using an automated hematology analyzer
J Lab Clin Med, 146, 36-42 (2005)

147. Koike H., Hirayama M., Yamamoto M., Ito H., Hattori N., Umehara F., Arimura K., Ikeda S., Ando Y., Nakazato M., Kaji R., Hayasaka K., Nakagawa M., Sakoda S., Matsumura K., Onodera O., Baba M., Yasuda H., Saito T., Kira J., Nakashima K., Oka N., Sobue G.
Age associated axonal features in HNPP with 17p11.2 deletion in Japan
J Neurol Neurosurg Psychiatry, 76, 1109-1114 (2005)

148. Hirai T., Ando Y., Yamura M., Kitajima M., Hayashida Y., Korogi Y., Yamashita T., Yamashita Y.
Transthyretin-related familial amyloid polyneuropathy: Evaluation of CSF enhancement on Serial T1-weighted and FLAIR images following intravenous contrast administration
Am J Neuroradiol, 26, 2043-2048 (2005)

149. Nakamura M., Ando Y., Sasada K., Haraoka K., Ueda M., Okabe H., Motomiya Y.
Role of extracellular superoxide dismutase (EC-SOD) in patients under maintenance hemodialysis
Nephron Clin Pract, 101, c109-c115 (2005)

150. Matsunaga N., Anan I., Rosenberg P., Nagai R., Lundstrom O., Horiuchi S., Ando Y., Suhr OB.
Advanced glycation end product is implicated in amyloid-related kidney complications
Scand J Clin Lab Invest, 65, 263-272 (2005)

151. Saito S., Ando Y., Nakamura M, Ueda M., Kim J., Ishima Y., Akaike T., Otagiri M.
Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis
Biochemistry, 44, 11122-11129 (2005)

152. Nakamura T., Watanabe H., Hirayama M., Inukai A., Kabasawa H., Matsubara M., Mitake S., Nakamura M., Ando Y., Uchino M., Sobue G.
CADASIL with NOTCH3 S180C presenting anticipation of onset age and hallucinations
J Neurol Sci, 238, 87-91 (2005)

153. Kawaji T., Ando Y., Nakamura M., Yamamoto K., Ando E., Takano A., Inomata Y., Hirata A., Tanihara H.
Transthyretin synthesis in rabbit ciliary pigment epithelium
Exp Eye Res, 81, 306-312 (2005)

154. Nakamura M., Yamashita T., Ueda M., Obayashi K., Sato T., Ikeda T., Washimi Y., Hirai T., Kuwahara Y., Yamamoto MT., Uchino M., Ando Y.
Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis
Neurology, 65, 1051-1056 (2005)

155. Takei Y., Ikeda S., Ikegami T., Hashikura Y., Miyagawa S., Ando Y., Japanese Liver Transplantation Society
Ten years of experience with liver transplantation for familial amyloid polyneuropathy in Japan: outcomes of living donor liver transplantations
Intern Med, 44, 1151-1156 (2005)

156. Mitsuhashi S., Yazaki M., Tokuda T., Sekijima Y., Washimi Y., Shimizu Y., Ando Y., Benson MD., Ikeda S.
Biochemical characteristics of variant transthyretins causing hereditary leptomeningeal amyloidosis
Amyloid, 12, 216-225 (2005)

157. Kawaji T., Ando Y., Nakamura M., Yamashita T., Wakita M., Ando E., Hirata A., Tanihara T.
Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy ATTR Y114C
Ophthalmology, 112, 2212 (2005)

158. Sun X., Ueda M., Yamashita T., Nakamura M., Bergström., ZEledon-Raminez ME., Okajima M., Misumi S., Shoji S., Moyomiya Y., Ando Y.
Lipid droplets are present in amyloid deposits in familial amyloidotic polyneuropathy and dialysis related amyloidosis
Amyloid, 13, 20-23 (2006)

159. Rimessi P., Spitali P., Ando Y., Mazzaferro V., Pastorelli F., Tassinari CA., Calzolari E., Salvi F., Ferlini A.
Transthyretin RNA profiling in livers from transplanted patients affected with familial amyloidotic polyneuropathy and identification of a dual transcription start point
Liver Int., 26, 211-220 (2006)

160. Sato T., Ando Y., Susuki S., Mikami F., Ikemizu S., Nakamura M., Suhr O., Anraku M., Kai T., Suico MA., Shuto T., Yamagata Y., Kai F.
Chromium (III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation
FEBS lett, 580, 491-496 (2006)

161. Terazaki H., Ando Y., Fernandes R., Yamamura K., Maeda S., Saraiva M.J.
Immunization in familial amyloidotic polyneuropathy: counteracting deposition by immunization with a Y78F TTR mutant
Lab Invest, 86, 23-31 (2006)

162. Zeledon RME., Ando Y., Asonuma K., Nakamura M., Sun X., Ueda M., Fujii J., Inomata Y.
Effect of tacrolimus and partial hepatectomy on transthyretin (TTR) metabolism in rats: the double-edged sword effect of the liver
Transplant Int, 19, 233-238 (2006)

163. Wakita M., Kawaji T., Ando E., Koga T., Inatani M., Tanihara H., Ando Y.
Ocular decompression retinopathy following trabeculectomy with mitomycin C associated with familial amyloidotic polyneuropathy
Br J Ophthalmol, 90, 515-516 (2006)

164. Ueda M., Ando Y., Haraoka K., Katsuragi S., Terasaki Y., Sugimoto M., Sun X., Uchino M.
Aging and tansthyretin-related amyloidosis: pathologic examinations in pulmonary Amyloidosis
Amyloid, 13, 24-30 (2006)

165. Sakashita N., Ando Y., Haraoka K., Terazaki H., Yamashita T., Nakamura M., Takeya M.
Severe congestive heart failure with cardiac liver cirrhosis 10 years after orthotopic liver transplantation for familial amyloidotic polyneuropathy
Pathol Int, 56, 408-412 (2006)

166. Bergström J., Ueda M., Une Y., Sun X., Misumi S., Shoji S., Ando Y.
Analysis of amyloid fibrils in the cheetah (Acinonyx jubatus)
Amyloid, 13, 93-98 (2006)

167. Bergström J., Engström U., Yamashita T., Ando Y., Westermark P.
Surface exposed epitopes and structural heterogeneity of in vivo formed transthyretin amyloid fibrils
Biochem Biopys Res Commun, 348, 532-539 (2006)

168. Goto T., Yamashita T., Ueda M., Ohshima S., YOneyama K., Nakamura M., Nanjo H., Asonuma K., Inomata Y., Watanabe S., Uchino M., Tanaka K., Ando Y.
Iatrogenic amyloid neuropathy in a Japanese patient after sequential liver transplantation
Am J Transplant, 6, 2512-2515 (2006)

169. Wada Y., Ando Y., Kai N., Takahashi W., Kikukawa H., Nakanishi J., JInnouchi Y., Ueda S.
Lower urinary tract dysfunction in type 1 familial amyloidotic polyneuropathy in Kumamoto, Japan
Int J Urol, 13, 1475-1478 (2006)

170. Ueda M., Ando Y., Nakamura M., Tamashita T., Himeno S., Kim J., Sun X., Saito S., Tateishi T., Bergstrom J., Uchino M.
FK506 Inhibits Murine AA Amyloidosis: Possible Involvement of T Cells in Amyloidogenesis
J Rheumatol, 33, 2260-2270 (2006)

171. Ueda M., Ando Y., Hakamata Y., Nakamura M., Yamashita T., Obayashi K., Himeno S., Inoue S., Sato Y., Kaneko T., Takamune N., Misumi S., Shoji S., Uchino M., Kobayashi E.
A novel transgenic rat with human amyloidogenic transthyretin V30M
Biochem Biophys Res Commun, 352, 299-304 (2007)

172. Sato T., Susuki S., Suico MA., Miyata M., Ando Y., Mizuguchi M., Takeuchi M., Dobashi M., Shuto T., Kai H.
Endoplasmic reticulum quality control regulates the fate of transthyretin variants in the cell
EMBO J, 26, 2501-2512 (2007)

173. Koide-Yoshida S., Niki T., Ueda M., Himeno S., Taira T., Iguchi-Ariga SM., Ando Y., Ariga H.
DJ-1 degrades transthyretin and an inactive form of DJ-1 is secreted in familial amyloidotic polyneuropathy
Int J Mol Med, 19, 885-893 (2007)

174. Bergström J., Patrosso MC., Colussi G., Salvadore M., Penco S., Lando G., Marocchi A., Ueda A., Nakamura M., Ando Y.
A novel type of familial transthyretin amyloidosis, ATTR Asn124Ser, with co-localization of κ light chains
Amyloid, 14, 141-145 (2007)

175. Inomata Y., Zeledon ME., Asonuma K., Okajima H., Takeichi T., Ishiko T., Ando Y.
Whole-Liver Graft Without the Retrohepatic Inferior Vena Cava for Sequential (Domino) Living Donor Liver Transplantation
Am J Transplant, 7, 1629-1632 (2007)

176. Yamamoto S., Wilczek H. E., Nowak G., Larsson M., Oksanen A., Iwata T., Gjertsen H., Söderdahl G., Wikström L., Ando Y., Suhr OB., Ericzon B G.
Liver Transplantation for Familial Amyloidotic Polyneuropathy (FAP): A Single Center Experience over 16 years
Am J Transplant, 7, 2597-2604 (2007)

177. Goto S., Seo T., Hagiwara T., Ueda K., Yamauchi T., Nagata S., Ando Y., Ishitsu T., Nakagawa K.
Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients
J Pharm Pharmacol, 60, 267-272 (2008)

178. Yamashita T., Ando Y., Ueda M., Nakamura M., Okamoto S., Zeledon ME., Hirahara T., Hirai T., Ueda A., Misumi Y., Obayashi K., Inomata H., Uchino M.
Effect of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy
Neurology, 70, 123-128 (2008)

179. Susuki S., Ando Y., Sato T., Nishiyama M., Miyata M., Suico MA., Shuto T., Kai H.
Multi-elemental analysis of serum and amyloid fibrils in familial amyloid polyneuropathy patients
Amyloid, 15, 108-116 (2008)

180. Kim J., Motomiya Y., Nakamura M., Ueda M., Misumi Y., Saito S., Ikemizu S., Misumi S., Ota K., Shinriki S., Kai H., Ando Y.
Conformational changes in the C-terminal of β2-microglobulin enhance amyloid fibril formation with and without ultrasonication
Ann Clin Biochem, 45, 489-495 (2008)

181. Obayashi K., Sato K., Shimazaki R., Ishikawa T., Goto K., Ueyama H., Mori T., Ando Y., Kumamoto T.
Salivary chromogranin A: useful and quantitative biochemical marker of affectiv e state in patients with amyotrophic lateral sclerosis
Intern Med, 47, 1875-189 (2008)

182. Okamoto S., Yamashita T., Ando Y., Ueda M., Misumi Y., Obayashi K., Horibata Y., Uchino M.
Evaluation of myocardial changes in familial amyloid polyneuropathy after liver transplantation
Intern Med, 47, 2133-2137 (2008)

183. Koike H., Kawagashira Y., Iijima M., Yamamoto M., Hattori N., Tanaka F., Hirayama M., Ando Y., Ikeda S., Sobue G.
Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci
J Neurol, 255, 1526-1533 (2008)

184. Ota K., Fujimori H., Ueda M., Shinriki S., Kudo M., Jono H., Fukuyoshi Y., Yamamoto Y., Sugiuchi H., Iwase H., Shinohara M., Ando Y.
Midkine as a prognostic biomarker in oral squamous cell carcinoma
Br J Cancer, 99, 655-662 (2008)

185. Kudo M., Jono H., Shinriki S., Yano S., Nakamura H., Makino K., Hide T., Muta D., Ueda M., Ota K., Ando Y., Kuratsu JI.
Antitumor effect of humanized anti-interleukin-6 receptor antibody (tocilizumab) on glioma cell proliferation
J Neurosurg, 111, 219-225 (2009)

186. Ueda M., Misumi Y., Mizuguchi M., Nakamura M., Yamashita T., Sekijima Y., Ota K., Shinriki S., Jono H., Ikeda SI., Suhr OB., Ando Y.
SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy
Clin Chem, 55, 1223-1227 (2009)

187. Tabata M., Kadomatsu T., Fukuhara S., Miyata K., Ito Y., Endo M., Urano T., Zhu HJ., Tsukano H., Tazume H., Kaikita K., Miyashita K., Iwawaki T., Shimabukuro M., Sakaguchi K., Ito T., Nakagata N., Yamada T., Katagiri H., Kasuga M., Ando Y., Ogawa H., Mochizuki N., Itoh H., Suda T., Oike Y.
Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance
Cell Metab, 10, 178-188 (2009)

188. Ibusuki M., Fujimori H., Yamamoto Y., Ota K., Ueda M., Shiniriki S., Taketomi M., Sakuma S., Shinohara M., Iwase H., Ando Y.
Midkine in plasma as a novel breast cancer marker
Cancer Sci, 100, 1735–1739 (2009)

189. Shinriki S., Ueda M., Ota K., Nakamura M., Kudo M., Ibusuki M., Kim J., Yoshitake Y., Fukuma D., Jono H., Kuratsu JI., Shinohara M., Ando Y.
Aberrant expression of serum amyloid A in head and neck squamous cell carcinoma
J Oral Pathol Med, 39, 41-47 (2009)

190. Uchiba M., Imamura T., Hata H., Tatetsu H., Yonemura Y., Ueda M., Wada Y., Mitsuya H., Ando Y.
Excessive fibrinogenesis in AL-amyloidosis is induced by urokinase-type plasminogen activator from bone marrow plasma cells
Amyloid, 16, 89-93 (2009)

191. Uji Y., Motomiya Y., Ando Y.
A circulating beta(2)-microglobulin intermediate inhemodialysis patients
Nephron Clin Pract, 111, c173-c181 (2009)

192. Susuki S., Sato T., Miyata M., Momohara M., Suico MA., Shuto T., Ando Y., Kai H.
The endoplasmic reticulum-associated degradation of transthyretin variants is negatively regulated by BiP in mammalian cells
J Biol Chem, 284, 8312-8321 (2009)

193. Yamashita T., Ando Y., Ueda M., Okamoto S., Misumi Y., Nakamura M., Takashi O., Uchino M.
A rapid and sensitive prenatal diagnosis of familial amyloidotic polyneuropathy
Prenat Diagn, 29, 930-933 (2009)

194. Koike H., Morozumi S., Kawagashira Y., Iijima M., Yamamoto M., Hattori N., Tanaka F., Nakamura T., Hirayama M., Ando Y., Ikeda SI., Sobue G.
The significance of carpal tunnel syndrome in transthyretin Val30Met familial amyloid polyneuropathy
Amyloid, 16, 142-148 (2009)

195. Koike H., Ando Y., Ueda M., Kawagashira Y., Iijima M., Fujitake J., Hayashi M., Yamamoto M., Mukai E., Nakamura T., Katsuno M., Hattori N., Sobue G.
Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy
J Neurol Sci, 287, 178-184 (2009)

196. Shinriki S., Jono H., Ota K., Ueda M., Kudo M., Ota T., Oike Y., Endo M., Ibusuki M., Hiraki A., Nakayama H., Yoshitake Y., Shinohara M., Ando Y.
Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma
Clin Cancer Res, 15, 5426-5434 (2009)

197. Misumi Y., Ando Y., Ueda M., Obayashi K., Jono H., Su Y., Yamashita T., Uchino M.
Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy
J Pathol, 219, 481-90 (2009)

198. Okamoto S., Wixner J., Obayashi K., Ando Y., Ericzon BG., Friman S., Uchino M., Suhr OB.
Liver transplantation for familial amyloidotic polyneuropathy, impact on Swedish patients' survival
Liver Transpl, 15, 1229-1235 (2009)

199. Anan I., Kiuru-Enari S., Obayashi K., Ranløv PJ., Ando Y.
Investigation of AGE, their receptor and NF-kappaB activation and apoptosis in patients with ATTR and Gelsolin amyloidosis
Histol Histopathol, 25, 691-699 (2010)

200. Arima H., Yamashita S., Mori Y., Hayashi Y., Motoyama K., Hattori K., Takeuchi T., Jono H., Ando Y., Hirayama F., Uekama K.
In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/α-cyclodextrin
conjugates (G2) into hepatocytes
J Control Release, 146, 106-117 (2010)

201. Hirohata M., Yoshita M., Ishida C., Ikeda SI., Tamaoka A., Kuzuhara S., Shoji M., Ando Y., Tokuda T., Yamada M.
Clinical features of non-hypertensive lobar intracerebral hemorrhage related to cerebral amyloid angiopathy
Eur J Neurol, 17, 823-829 (2010)

202. Hara R., Kawaji T., Ando E., Ohya Y., Ando Y., Tanihara H.
Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients
Arch Ophthalmol, 128, 206-210 (2010)

203. Ito Y., Takakura S., Ichiyama S., Ueda M., Ando Y., Matsuda K., Hidaka E., Nakatani K., Nishioka J., Nobori T., Kajiyama N., Kimura H.
Multicenter evaluation of prototype real-time PCR assays for Epstein-Barr virus and cytomegalovirus DNA in whole blood samples from transplant recipients
Microbiol Immunol, 54, 516-522 (2010)

204. Kono S., Manabe Y., Tanaka T., Fujii D., Sakai Y., Narai H., Omori N., Ueda M., Ando Y., Abe K.
A case of familial amyloid polyneuropathy due to Phe33Val TTR with vitreous involvement as the initial manifestation
Intern Med, 49, 1213-1216 (2010)

205. Kawaji T., Ando Y., Ando E., Sandgren O., Suhr OB.
Transthyretin-related vitreous amyloidosis in different endemic areas
Amyloid, 17, 105-108 (2010)

206. Kawaji T., Ando Y., Hara R., Tanihara H.
Novel therapy for transthyretin-related ocular amyloidosis A pilot study of retinal laser photocoagulation
Ophthalmology, 17, 552-555 (2010)

207. Obayashi K., Ueda M., Yamashita T., Misumi Y., Hirahara T., Tasaki M., Ohshima T., Uchino M., Ando Y.
Gastric myoelectrical activities in elderly severe tetanus: Useful marker to increase volume and calorie of nasogastric tube feeding
e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, 5, e261-e264 (2010)

208. Ohya Y., Jono H., Nakamura M., Hayashida S., Ueda M., Obayashi K., Misumi S., Asonuma K., Ando Y., Inomata Y.
Effect of recipient-derived cells on the progression of familial amyloidotic polyneuropathy after liver transplantation: a retrospective study
Ann Clin Biochem, 47, 529-534 (2010)

209. Ota T., Ota K., Jono H., Fujimori H., Ueda M., Shinriki S., Sueyoshi T., Shinohara M., Ando Y.
Midkine expression in malignant salivary gland tumors and its role in tumor angiogenesis
Oral Oncol, 37, 797-804 (2010)

210. Tasaki M., Ueda M., Ochiai S., Tanabe Y., Murata S., Misumi Y., Su Y., Sun X., Shinriki S., Jono H., Shono M., Obayashi K., Ando Y.
Transmission of circulating cell-free AA amyloid oligomers in exosomes vectors via a prion-like mechanism
Biochem Biopys Res Commun, 400, 559-562 (2010)

211. Zhang P., Fu X., Sawashita J., Yao J., Zhang B., Qian J., Tomozawa H., Mori M., Ando Y., Naiki H., Higuchi K.
Mouse model to study human A beta2M amyloidosis: generation of a transgenic mouse with excessive expression of human beta2-microglobulin
Amyloid, 17, 50-62 (2010)

212. Asahina A., Yokoyama T., Ueda M., Ando Y., Ohshima N., Saito I., Tadokoro E., Hasegawa K.
Hereditary gelsolin amyloidosis: a new Japanese case with cutis laxa as a diagnostic clue
Acta Derm Venereol, 91, 201-203 (2011)

213. Asahina M., Akaogi Y., Misawa S., Kanai K., Ando Y., Sakakibara R., Arai K., Hattori T., Kuwabara S.
Sensorimotor manifestations without autonomic symptoms in two siblings with TTR Val107 familial amyloid polyneuropathy
Clin Neurol Neurosurg, 113, 139-141 (2011)

214. Ando Y.
Cover legend: a membership of the editorial academy of International Journal of Oncology
International Journal of Oncology, 39, 299-300 (2011)

215. Berk JL., Dyck PJ., Obici L., Zeldenrust SR., Sekijima Y., Yamashita T., Ando Y., Ikeda SI., Gorevic P., Merlini G., Kelly JW., Skinner M., Bisbee AB., Suhr OB. Familial Amyloidosis Consortium. The diflunisal trial: update on study drug tolerance and disease progression
Amyloid, 18, Suppl.1, 191-192 (2011)

216. Guo J., Jono H., Kugimiya T., Saito S., Maruyama T., Misumi Y., Hoshii Y., Su Y., Ueda M., Otagiri M., Ando Y.
Antioxidative effect of albumin on transthyretin-related amyloidosis
Amyloid, 18, Suppl.1, 17-18 (2011)

217. Ibusuki M., Yamamoto Y., Shinriki S., Ando Y., Iwase H.
Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients
Cancer Sci, 102, 439-445 (2011)

218. Jono H., Anno T., Misumi Y., Mori Y., Motoyama K., Ueda M., Horibata Y., Shono M., Obayashi K., Arima H., Ando Y.
Effect of cyclodextrins on transthyretin amyloid formation
Amyloid, 18, Suppl.1, 58-59 (2011)


219. Jono H., Anno T., Motoyama K., Misumi Y., Tasaki T., Oshima T., Mori Y., Mizuguchi M., Ueda M., Shono M., Obayashi K., Arima H., Ando Y.
Cyclodextrin, a novel therapeutic tool for suppressing amyloidogenic transthyretin misfolding in transthyretin-related amyloidosis
Biochem J, 437, 35-42 (2011)

220. Kawahara S., Ueda M., Miyazaki A., Urasaki Y., Horibata Y., Jono H., Obayashi K., Ikeda K., Tanase S., Ando Y., Ueda M.
Age-dependent increase in thiol conjugated forms of transthyretin (TTR) in the eldely: quantitative analyses by the SELDI-TOF MS protein chip system
Amyloid, 18, Suppl.1, 14-16 (2011)

221. Kumabe Y., Miura A., Yamashita T., Oshima T., Misumi Y., Ueda M., Obayashi K., Horibata Y., Jono H., Ando Y., Uchino M.
A homozygote case of FAP ATTR Val30Met in a non-endemic area
Amyloid, 18, Suppl.1, 169-170 (2011)

222. Kugimiya T., Jono H., Saito S., Maruyama M., Kadowaki D., Misumi Y., Hoshii Y., Tasaki T., Su Y., Ueda M., Obayashi K., Shono M., Otagiri M., Ando Y.
Loss of functional albumin triggers acceleration of transthyretin amyloid fibril formation in familial amyloidotic polyneuropathy
Lab Invest, 91, 1219-1228 (2011)

223. Koike H., Kiuchi T., Iijima M., Ueada M., Ando Y., Morozumi S., Tomita M., Kawagashira Y., Watanabe H., Katsuno M., Shimoyama Y., Okazaki Y., Kamei H., Sobue G.
Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation
J Neurol NeuroSurg Psychiatry, 82, 1287-1290 (2011).

224. Misumi Y., Ueda M., Obayashi K., Jono H., Su Y., Yamashita T., Ohshima T., Ando Y., Uchino M.
Relationship between amyloid deposition and intracellular structural changes in familial amyloidotic polyneuropathy
Human Pathol, 43, 96-104 (2011)

225. Misumi Y., Ando Y., Ueda M., Obayashi K., Jono H., Su Y., Yamashita T., Uchino M.
Relationship between amyloid fibril formation and overproduction of basement membrane components in FAP
Amyloid, 18, Suppl.1, 22-23 (2011)

226. Morizane R., Monkawa T., Konishi K., Hashiguchi A., Ueda M., Ando Y., Tokuyama H., Hayashi H., Hayashi M., Itoh H.
Renal amyloidosis caused by apolipoprotein A--II without a genetic mutation in the　coding sequence
Clin Exper Nephorol, 15, 774-779 (2011)

227. Murata S., Ueda M., Tanabe Y., Kurata N., Demura N., Gram H., Tasaki M., Su Y., Jono H., Shono M., Obayashi K., Ando Y.
Inhibitory effects of anti-IL-1 beta antibody in murine AA amyloidosis model
Amyloid, 18, Suppl.1, 38-39 (2011)

228. Obayashi K., Hornsten R., Wiklund U., Karlsson M., Okamoto S., Ando Y., Suhr OB.
Haemodynamic responses after tilt reversal in FAP
Amyloid, 18, Suppl.1, 166-168 (2011)

229. Obayashi K., Ueda M., Misumi Y., Yamashita T., Jono H., Tasaki M., Shono M., Yazaki M., Kametani F., Ohya Y., Asonuma K., Inomata Y., Ikeda SI., Ando Y.
Amyloid turnover after liver transplantation in FAP
Amyloid, 18, Suppl.1, 187-189 (2011)

230. Obayashi K., Yamashita T., Tasaki M., Ueda M., Shono M., Jono H., Ohshima T., Ohya Y., Asonuma K., Inomata Y., Ando Y.
Amyloid neuropathy in a younger domino liver transplanted recipient
Muscle Nerve, 43, 449-450 (2011)

231. Obayashi K., Hörnsten R., Wiklund U., Karlsson M., Okamoto S., Ando Y., Suhr OB.
Blood pressure overshoot after tilt reversal in patients with familial amyloidotic polyneuropathy
Hypertension Res, 34, 133-138 (2011)

232. Okamoto S., Wixner J., Ericzon BG., Friman S., Lindqvist P., Henein M., Suhr O B.
Prognostic value of pre-transplant cardiomyopathy in Swedish liver transplanted patients for familial amyloidotic polyneuropathy
Amyloid, 18, Suppl.1, 171-173 (2011)

233. Ohya Y., Okamoto S., Tasaki M., Ueda M., Jono H., Obayashi K., Takeda K., Okajima H., Asonuma K., Hara R., Tanihara H., Ando Y., Inomata Y.
Manifestations of transthyretin-related familial amyloidotic polyneuropathy: long-term follow-up of Japanses patients after liver transplantation
Surg Today, 41, 1211-1218 (2011)

234. Okabe H., Beppu T., Hayashi H., Ishiko T., Masuda T., Otao R., Horlad H., Jono H., Ueda M., Ando Y., Baba H.
Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells
Ann Surg Oncol, 18, 1175-1184 (2011)

235. Su Y., Horibata Y., Ueda M., Tasaki M., Misumi Y., Jono H., Obayashi K., Ogawa H., Ando Y.
Transthyretin-derived amyloid deposition in the heart of Japanese elderly
Amyloid, 18, Suppl.1, 180-181 (2011)

236. Sueyoshi T., Ueda M., Jono H., Tasaki M., Irie H., Sei A., Ide J., Ando Y., Mizuta H.
Wild type transthyretin-derived amyloidosis in ligaments and tendons of various organ sites
Human Pathol, 42, 1259-1264 (2011)

237. Sueyoshi T., Ueda M., Jono H., Horibata Y., Shono M., Obayashi K., Sei A., Mizuta H., Ando Y.
Transthyretin-derived amyloid deposition in ligaments and tendons of various organ sites
Amyloid, 18, Suppl.1, 163-165 (2011)

238. Sueyoshi T., Ueda M., Sei A., Misumi Y., Oshima T., Yamashita T., Obayashi K., Shinriki S., Jono H., Shono M., Ando Y., Mizuta H.
Spinal multifocal amyloidosis derived from wild-type transthyretin
Amyloid, 18, 165-168 (2011)

239. Shinriki S., Jono H., Ueda M., Ota K., Ota T., Sueyoshi T., Oike Y., Ibusuki M., Hiraki A., Nakayama H., Shinohara M., Ando Y.
Interleukin-6 signaling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma.
J Pathol, 225, 142-150 (2011)

240. Sueyoshi T., Jono H., Shinriki S., Ota K., Ota T., Tasaki M., Atsuyama E., Yakushiji T., Ueda M., Obayashi K., Mizuta H., Ando Y. Therapeutic approaches targeting midkine suppress tumor growth and lung metastasis in osteosarcoma
Cancer Lett, 316, 23-30 (2011)

241. Ueda M., Horibata Y., Shono M., Misumi Y., Oshima T., Su Y., Tasaki M., Shinriki S., Kawahara S., Jono H., Obayashi K., Ogawa H., Ando Y.
Clinicopathological features of senile systemic amyloidosis: an ante- and postmortem study
Modern Pathol, 24, 1533-1544 (2011)

242. Yamashita T., Ando Y., Okamoto S., Yohei M., Hirahara T., Ueda M., Obayashi K., Nakamura M., Jono H., Asonuma K., Inomata Y., Uchino M.
Effect of liver transplantation on the survival of patients with ordinary onset FAP in Japan
Amyloid, 18, Suppl.1, 185-186 (2011)

243. Asonuma K., Ohya Y., Isono K., Takeichi T., Yamamoto H., Lee KJ., Okumura K., Ando Y., Inomata Y.
Current state of domino transplantation in Japan in terms of surgical procedures and de novo amyloid neuropathy
Amyloid, 19, Suppl.1, 75-77 (2012)

244. Hayashi Y., Mori Y., Higashi T., Motoyama K., Jono H., Sah DW., Ando Y., Arima H.
Systemic delivery of transthyretin siRNA mediated by lactosylated dendrimer/α-cyclodextrin conjugates into hepatocyte for familial amyloidotic polyneuropathy therapy
Amyloid, 19, Suppl.1, 47-49 (2012)

245. Jono H., Anno T., Motoyama K., Misumi Y., Tasaki M., Oshima T., Mori Y., Mizuguchi M., Ueda M., Shinriki S., Shono M., Obayashi K., Arima H., Ando Y.
Potential use of glucuronylglucosyl-β-cyclodextrin as a novel therapeutic tool for familial amyloidotic polyneuropathy
Amyloid, 19, Suppl.1, 50-52 (2012)

246. Misumi Y., Ueda M., Obayashi K., Jono H., Yamashita T., Ando Y.
Interaction between amyloid fibril formation and extracellular matrix in the proceedings of VIIIth International Symposium on Familial Amyloidotic Polyneuropathy
Amyloid, 19, Suppl.1, 8-10 (2012)

247. Obayashi K. & Ando Y.
Focus on autonomic dysfunction in familial amyloidotic polyneuropathy (FAP)
Amyloid, 19, Suppl.1, 28-29 (2012)

248. Okabe H., Beppu T., Ueda M., Hayashi H., Ishiko T., Masuda T., Otao R., Horlad H., Mima K., Miyake K., Iwatsuki M., Baba Y., Takamori H., Jono H., Shinriki S., Ando Y. & Baba H.
Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts
Int J Cancer, 131, 2234-2241 (2012)

249. Ota T., Jono H., Ota K., Shinriki S., Ueda M., Sueyoshi T., Nakatani K., Hiraishi Y., Wada T., Fujita S., Obayashi K., Shinohara M. & Ando Y.
Downregulation of midkine induced cisplatin resistance in human squamous cell cartinoma
Onco report, 27, 1674-1680 (2012)
250. Su Y., Jono H., Misumi Y., Senokuchi T., Guo J., Ueda M., Shinriki S., Tasaki M., Shono M., Obayashi K., Yamagata K., Araki E., Ando Y.
Novel function of transthyretin in pancreatic alpha cells
FEBS Lett, 586, 4215-4222 (2012)

251. Su Y., Jono H., Torikai M., Hosoi A., Soejima K., Guo J., Tasaki M., Misumi Y., Ueda M., Shinriki S., Shono M., Obayashi K., Nakashima T., Sugawara K. & Ando Y.
Antibody therapy for familial amyloidotic polyneuropathy
Amyloid, 19, Suppl.1, 45-46 (2012)

252. Su Y., Misumi Y., Ueda M., Shono M., Tasaki M., Jono H., Obayashi K., Senokuchi T., Yamagata K. & Ando Y.
The occurrence of islet amyloid polypeptide amyloidosis in Japanese subjects
Pancreas, 41, 971-973 (2012)

253. Obayashi K., Ueda M., Oshima T., Kawahara S., Misumi Y., Yamashita T., Jono H., Yazaki M., Kametani F., Ikeda S., Ohya Y., Asonuma K., Inomata Y., Ando Y.
Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient
BMJ Case Rep, 2012 Aug 18;2012. pii: bcr2012006593. doi: 10.1136/bcr-2012-006593.

254. Uji Y., Motomiya Y., Ando Y.
Effect of heparin on conformation of the β(2) -microglobulin molecule
Ther Apher Dial, 16, 159-62 (2012)

255. Yamashita T., Ando Y., Okamoto S., Misumi Y., Hirahara T., Ueda M., Obayashi K., Nakamura M., Jono H., Shono M., Asonuma M., Inomata Y., Uchino M.
Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy
Neurology, 78, 637-643 (2012)

256. Kinoshita H., Okabe H., Beppu T., Chikamoto A., Hayashi H., Imai K., Mima K., Nakagawa S., Yokoyama N., Ishiko T., Shinriki S., Jono H., Ando Y., Baba H.
CYLD downregulation is correlated with tumor development in patients with hepatocellular carcinoma
Molecular Clin Oncol, 1, 309-314 (2013)

257. Misumi Y., Ando Y., Gonçalves NP., Saraiva MJ.
Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis
Lab Invest, 93, 911-920 (2013)

258. Matsuo Y., Yamashita S., Honda S., Nakajima M., Ueda A., Hirahara T., Yamashita T., Maeda Y., Hirano T., Ando Y.
Bilateral basal ganglia lesions as initial manifestation of CNS invasion in adult T-cell leukemia
J Neurol Sci, 327, 63-64 (2013)

259. Obayashi K., Misumi Y., Watanabe T., Ando T., Akagami T., Tasaki M., Shinriki S., Ueda M., Yamashita T., Hirotani S., Ando Y.
Dominant cardiac type of familial amyloidotic polyneuropathy associated with a novel transthyretin variant Thr59Arg
Muscle Nerve, 48, 839-841 (2013)

260. Hayashi Y, Higashi T, Motoyama K, Mori Y, Jono H, Ando Y., Arima H.
Design and evaluation of polyamidoamine dendrimer conjugate with PEG, α-cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in vivo
J Drug Target, 21, 487-496 (2013)

261. Obayashi K., Tasaki M., Jono H., Ueda M., Shinriki S., Misumi Y., Yamashita T., Oshima T., Nakamura T., Ikemizu S., Anan I., Suhr O., Ando Y.
Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30Methionine
Clin Chim Acta, 419, 127-131 (2013)

262. Ohya Y., Isono K., Obayashi K., Hayashida S., Lee KJ., Yamamoto H., Takeichi T., Asonuma K., Ando Y., Inomata Y.
Peritransplant gastrointestinal symptoms in familial amyloidotic polyneuropathy
Exp Clin Transplant, 11, 327-331 (2013)

263. Sakashita N., Kagawa S., Date R., Ueno T., Nakagawa T., Yamashita T., Obayashi K., Ohshima T., Ueda M., Horiguchi H., Ando Y. & Takeya M.
Marked cardiomegaly in a patient with familial amyloidotic polyneuropathy after orthotopic liver transplantation: a case study
Pathol Int, 63, 260-265 (2013)

264. Somekawa-Kondo T., Yamaguchi K., Ishitsuka Y., Itoa S., Tanaka K., Irikura M., Moriuchi H., Takahama K., Ando Y., Yamasaki T., Irie T.
Aminophylline, administered at usual doses for rodents in pharmacological studies, induces hippocampal neuronal cell injury under low tidal volume hypoxic conditions in guinea-pigs
J Pharm Phatmacol, 65, 102-114 (2013)

265. Ihse E, Rapezzi C., Merlini G., Benson MD., Ando Y., Suhr OB., Ikeda S., Lavatelli F., Obici L., Quarta CC., Leone O., Jono H., Ueda M., Lorenzini M., Liepnieks J., Ohshima T., Tasaki M., Yamashita T., Westermark P.
Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR
Amyloidosis
Amyloid, 20, 142-150 (2013)

266. Tasaki M., Ueda M., Obayashi K., Koike H., Kitagawa K., Ogi Y., Jono H., Su Y., Suenaga G., Oshima T., Misumi Y., Yoshida M., Yamashita T., Sobue G., Ando Y.
Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: A proteomic approach
Int J Cardiol, 170, 69-74 (2013)

267. Taguchi K., Jono H., Kugimiya-Taguchi T., Nagao S., Su Y., Yamasaki K., Mizuguchi M., Maruyama T., Ando Y., Otagiri M.
Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy
Life Sci, 93, 1017-1022 (2013)

268. Uchino M., Yamashita S., Uchino K., Mori A., Hara A., Suga T., Hirahara T., Koide T., Kimura E., Yamashita T., Ueda A., Kurisaki R., Suzuki J., Honda S., Maeda Y., Hirano T., Ando Y.
Muscle biopsy findings predictive of malignancy in rare infiltrative dermatomyositis
Clin Neurol Neurosurg, 115, 603-606 (2013)

269. Usuku H., Obayashi K., Shono M., Oshima T., Tasaki M., Yasuda H., Ogawa H., Ando Y.
Usefulness of plasma B-type natriuretic peptide as a prognostic marker of cardiac function in senile systemic amyloidosis and in familial amyloidotic polyneuropathy
Amyloid, 20, 251-255 (2013)

270. Wixner J., Obayashi K., Ando Y., Karling P., Anan I.
Loss of gastric interstitial cells of Cajal in patients with hereditary transthyretin amyloidosis
Amyloid, 20, 99-106 (2013)

271. Yamashita S., Kimura E., Tawara N., Sakaguchi H., Nakama T., Maeda Y., Hirano T., Uchino M., Ando Y.
Optineurin is potentially associated with TDP-43 and involved in the pathogenesis of inclusion body myositis
Neuropathol Appl Neurobiol, 39, 406-416 (2013)

272. Berk JL., Suhr OB., Obici L., Sekijima Y., Zeldenrust SR., Yamashita T., Heneghan MA., Gorevic PD., Litchy WJ., Wiesman JF., Nordh E., Corato M., Lozza A., Cortese A., Robinson-Papp J., Colton T., Rybin DV., Bisbee AB., Ando Y., Ikeda S., Seldin DC., Merlini G., Skinner M., Kelly JW., Dyck PJ. Diflunisal Trial Consortium.
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.
JAMA, 310, 2658-2667 (2013)

273. Inoue Y., Watanabe M., Ando Y.
Brain infarction with a predilection for cerebellum in a patient with double-outlet left ventricle and vascular malformations
J Stroke Cerebrovasc Dis, 23, 1232-1234 (2014)

274. Kawano H., Nakajima M., Inatomi Y., Yonehara T., Ando Y.
Loading dose of clopidogrel in combination with other antithrombotic therapy for capsular warning syndrome
J Stroke Cerebrovasc Dis, 23, 1265-1266 (2014)

275. Usuku H., Izumiya Y., Sugiyama S., Kojima S., Araki S., Kurogi K., Yamamoto N., Ando Y., Ogawa H.
Lower Framingham risk score and the absence of hypertension are associated with the morning peak in the circadian variation of ST-elevation myocardial infarction onset
Hypertens Res, 37, 239-245 (2014)

276. Hayashi M., Jono H., Shinriki S., Nakamura T., Guo J., Sueta A., Tomiguchi M., Fujiwara S., Yamamoto-Ibusuki M., Murakami KI., Yamashita S., Yamamoto Y., Li JD., Iwase H., Ando Y.
Clinical significance of CYLD downregulation in breast cancer
Breast Cancer Res Treat, 143, 447-457 (2014)

277. Hirahara T., Yamashita S., Misumi Y., Kawakami K., Hori H., Honda S., Watanabe M., Ikeda T., Yamashita T., Maeda Y., Ando Y.
Gait disturbance due to foot drop is refractory to treatment in nonsystemic vasculitic neuropathy
Eur Neurol, 71, 180-186 (2014)

278. Yoshizawa T., Karim MF., Sato Y., Senokuchi T., Miyata K., Fukuda T., Go C., Tasaki M., Uchimura K., Kadomatsu T., Tian Z., Smolka C., Sawa T., Takeya M., Tomizawa K., Ando Y., Araki E., Akaike T., Braun T., Oike Y., Bober E., Yamagata K.
SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway
Cell Metab, 19, 712-721 (2014)

279. Honda S., Inatomi Y., Yonehara T., Hashimoto Y., Hirano T., Ando Y., Uchino M.
Discrimination of acute ischemic stroke from nonischemic vertigo in patients presenting with only imbalance
J Stroke Cerebrovasc Dis, 23, 888-895 (2014)

280. Oshima T., Kawahara S., Ueda M., Kawakami Y., Tanaka R., Okazaki T., Misumi Y., Obayashi K., Yamashita T., Ohya Y., Ihse E., Shinriki S., Tasaki M., Jono H., Asonuma K., Inomata Y., Westermark P., Ando Y.
Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation
J Neurol Neurosurg Psychiatry, 85, 740-746 (2014)

281. Nakajima M., Inatomi Y., Yonehara T., Hashimoto Y., Hirano T., Ando Y.
Temporal trends in oral intake ability 3 months after acute ischaemic stroke: Analysis of a single-centre database from 2003 to 2011
J Rehabil Med, 46, 200-205 (2014)

282. Yumura A., Hokazono E., Ikeda K., Obayashi K., Ando Y., Osawa S.
Development of the enzymatic assay for whole blood choline using an automated biochemical analyzer
Int J Anal Bio-Sci, 2, 23-32 (2014)

283. Kurisaki R., Yamashita S., Sakamoto T., Maruyoshi N., Uekawa K., Uchino M., Ando Y.
Decision making of amyotrophic lateral sclerosis patients on noninvasive ventilation to receive tracheostomy positive pressure ventilation
Clin Neurol Neurosurg, 125C, 28-31 (2014)

284. Guo J., Shinriki S., Su Y., Nakamura T., Hayashi M., Tsuda Y., Murakami Y., Tasaki M., Hide T., Takezaki T., Kuratsu JI., Yamashita S., Ueda M., Li JD., Ando Y., Jono H.
Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy
Oncotarget, 5, 6353-6364 (2014)
285. Anno T., Higashi T., Hayashi Y., Motoyama K., Jono H., Ando Y., Arima H.
Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a siRNA carrier for the treatment of familial amyloidotic polyneuropathy
J Drug Target, 22, 883-890 (2014)

286. Isono K., Jono H., Ohya Y., Shiraki N., Yamazoe T., Sugasaki A., Era T., Fusaki N., Tasaki M., Ueda M., Shinriki S., Inomata Y., Kume S., Ando Y.
Generation of familial amyloidotic polyneuropathy-specific induced pluripotent stem cells
Stem Cell Res, 12, 574-583 (2014)

287. Misumi Y., Doki T., Ueda M., Obayashi K., Tasaki M., Tamura A., Ando Y.
Myopathic phenotype of familial amyloid polyneuropathy with a rare transthyretin variant: ATTR Ala45Asp
Amyloid, 21, 216-217 (2014)

288. Nakahara K., Ueda M., Yamada K., Koide T., Yoshimochi G., Funayama M., Kim JH., Yamakawa S., Mori A., Misumi Y., Uyama E., Hattori N., Ando Y.
Juvenile-onset parkinsonism with digenic parkin and PINK1 mutations treated with subthalamic nucleus stimulation at 45years after disease onset
J Neurol Sci, 345, 276-277 (2014)


289. Hirahara T., Yamashita S., Misumi Y., Kawakami K., Hori H., Honda S., Watanabe M., Ikeda T., Yamashita T., Maeda Y., Ando Y.
Reply to Comments on 'Gait disturbance due to foot drop is refractory to treatment in nonsystemic vasculitic neuropathy'
Eur Neurol, 73, 80 (2014)
290. Nakahara K., Yamashita S., Ideo K., Shindo S., Suga T., Ueda A., Honda S., Hirahara T., Watanabe M., Yamashita T., Maeda Y., Yonemochi Y., Takita T., Ando Y.
Drastic therapy for listerial brain abscess involving combined hyperbaric oxygen therapy and antimicrobial agents
J Clin Neurol, 10, 358-362 (2014)

291. Yamashita S., Sakashita N., Yamashita T., Tawara N., Tasaki M., Kawakami K., Komohara Y., Fujiwara Y., Kamikawa M., Nakagawa T., Hirano T., Maeda Y., Hasegawa M., Takeya M., Ando Y.
Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration
J Neurol, 261, 2209-2217 (2014)

292. Kawano H., Yokota C., Yamamoto F., Mori Y., Mihara Y., Ando Y., Minematsu K.
Stroke education for multidisciplinary medical personnel in a rural area of Japan for promotion of hospital visit of acute stroke patients
J Stroke Cerebrovasc Dis, 23, 2372-2377 (2014)

293. Hori H., Yamashita S., Tawara N., Hirahara T., Kawakami K., Nishikami T., Maeda Y., Ando Y.
Clinical features of Japanese patients with inclusion body myositis
J Neurol Sci, 46, 133-137 (2014)

294. Misumi Y., Ando Y.
Classification of amyloidosis
Brain Nerve, 66, 731-737 (2014)

295. Nakazono M., Obayashi K., Sasamoto K., Tomiyoshi K., Suenaga G., Ando Y.
Novel styrylbenzene derivatives for detecting amyloid deposits
Clin Chim Acta, 436, 27-34 (2014)

296. Kajihara R., Sakamoto H., Tanabe K., Takemoto K., Tasaki M., Ando Y., Inui S.
Protein phosphatase 6 controls BCR-induced apoptosis of WEHI-231 cells by regulating ubiquitination of Bcl-xL
J Immunol, 192, 5720-5729 (2014)

297. Kawaji T., Inoue T., Hara R., Eiki D., Ando Y., Tanihara H.
Long-term outcomes and complications of trabeculectomy for secondary glaucoma in patients with familial amyloidotic polyneuropathy
PLoS One, 9, e96324 (2014)

298. Nakajima M., Inatomi Y., Yonehara T., Terasaki T., Ando Y.
Frequent ischemic events related to varying middle cerebral artery stenosis
Intern Med, 53, 797-800 (2014)

299. Nakajima M., Inatomi Y., Yonehara T., Hirano T., Ando Y.
Nontraumatic convexal subarachnoid hemorrhage concomitant with acute ischemic stroke
J Stroke Cerebrovasc Dis, 23, 1564-1570 (2014)

300. Nakamura T., Migita K., Ando Y., Takaoka H., Suzushima H., Shiraishi N.
Amyloid A amyloidosis in a Japanese patient with familial Mediterranean fever associated with homozygosity for the pyrin variant M694I/M694I
Mod Rheumatol, 24, 349-352 (2014)

301. Kobayashi J., Sato S., Okumura K., Miyashita F., Ueda A., Ando Y., Toyoda K.
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy without anterior temporal pole involvement: a case report
J Stroke Cerebrovasc Dis, 23, e241-242 (2014)

302. Takamatsu K., Ikeda T., Haruta M., Matsumura K., Ogi Y., Nakagata N., Uchino M., Ando Y., Nishimura Y., Senju S.
Degradation of amyloid beta by human induced pluripotent stem cell-derived macrophages expressing Neprilysin-2
Stem Cell Res, 13, 442-453 (2014)

303. Shinriki S., Jono H., Ueda M., Obayashi K., Nakamura T., Ota K., Ota T., Sueyoshi T., Guo J., Hayashi M., Hiraki A., Nakayama H., Yamashita S., Shinohara M., Ando Y.
Stromal expression of neutrophil gelatinase-associated lipocalin correlates with poor differentiation and adverse prognosis in oral squamous cell carcinoma
Histopathology, 64, 356-364 (2014)

304. Ikeda T., Hirata S., Takamatsu K., Haruta M., Tsukamoto H., Ito T., Uchino M., Ando Y., Nagafuchi S., Nishimura Y., Senju S.
Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells
PLoS One, 9, e115198 (2014)

305. Shinojima N., Nakamura H., Tasaki M., Kameno K., Anai S., Iyama KI., Ando Y., Seto H., Kuratsu JI.
A patient with medulloblastoma in its early developmental stage
J Neurosurg Pediatr, 14, 615-620 (2014)

306. Motomiya Y., Higashimoto Y., Uji Y., Suenaga G., Ando Y.
C-terminal unfolding of an amyloidogenic β2-microglobulin fragment: ΔN6β2-microglobulin
Amyloid, 19, 1-7 (2014)

307. Tasaki M., Ueda M., Matsumoto K., Kawaji T., Misumi Y., Eiki D., Suenaga G., Obayashi K., Yamashita T., Tanihara H., Ando Y.
Clinico-histopathological and biochemical analyses of corneal amyloidosis in gelatinous drop-like corneal dystrophy
Amyloid, 22, 67-69 (2015)

308. Ericzon BG., Wilczek H., Larsson M., Wijayatunga P., Stangou A., Pena JR., Frutado E., Barroso E., Daniel J., Samuel D., Adam R., Karam V., Poterucha J., Lewis D., Ferraz-Neto BH., Cruz MW., MUnar-Ques M., Fabregat JF., Ikeda S., Ando Y., Heaton N., Otto G., Suhr O.
Liver transplantation for hereditary transthyretin amyloidosis: After 20 years still the best therapeutic alternative?
Transplantation, 99, 1847-1854 (2015)

309. Nakajima M., Inatomi Y., Yonehara T., Watanabe M., Ando Y.
Outcome in patients admitted outside regular hospital working hours: Does time until regular working hours matter?
Int J Stroke, 10, 79-84 (2015)

310. Matsushima K., Sugiuchi H., Anraku K., Nishimura H., Manabe M., Ikeda K., Ando Y., Kondo Y., Ishitsuka Y., Irikura M., Irie T.
Differences in reaction specificity toward lipoprotein X and abnormal LDL among 6 homogeneous assays for LDL-cholesterol
Clin Chim Acta, 439, 29-37 (2015)

311. Naganuma M., Inatomi Y., Kobayashi O., Nishi T., Yonehara T., Ando Y.
Reappearance of free-floating carotid thrombus after discontinuation of anticoagulant therapy
J Stroke Cerebrovasc Dis, 24, e45-47 (2015)

312. Yanagisawa A., Ueda M., Sueyoshi T., Okada T., Fujimoto T., Ogi Y., Kitagawa K., Tasaki M., Misumi Y., Oshima T., Jono H., Obayashi K., Hirakawa K., Uchida H., Westermark P., Ando Y., Mizuta H.
Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis
Mod Pathol, 28, 201-207 (2015)

313. Ito Y., Nakajima M., Watari M., Sakamoto T., Hashimoto Y., Tajiri S., Takada A., Ando Y. Intratumoral hemorrhage in a patient with malignant meningioma under anticoagulant therapy
J Stroke Cerebrovasc Dis, 24, e91-92 (2015)

314. Wada N., Kawano Y., Fujiwara S., Kikukawa Y., Okuno Y., Tasaki M., Ueda M., Ando Y., Yoshinaga K., Ri M., Iida S., Nakashima T., Shiotsu Y., Mitsuya H., Hata H.
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells
Int J Oncol, 46, 963-972 (2015)

315. Nakamura T., Shinriki S., Jono H., Guo J., Ueda M., Hayashi M., Yamashita S., Zijlstra A., Nakayama H., Hiraki A., Shinohara M., Ando Y.
Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells
Oncotarget, 6, 1008-1019 (2015)

316. Nakamura T., Shinriki S., Jono H., Ueda M., Nagata M., Guo J., Hayashi M., Yoshida R., Ota T., Ota K., Kawahara K., Nakagawa Y., Yamashita S., Nakayama H., Hiraki A., Shinohara M., Ando Y.
Osteopontin-integrin αvβ3 axis is crucial for 5-fluorouracil resistance in oral squamous cell carcinoma
FEBS Lett, 589, 231-239 (2015)

317. Nishida Y., Ueda A., Ando Y., Ichikawa T.:
Skin biopsy-based diagnosis of CADASIL with atypical MRI findings
Intern Med, 54, 537-538 (2015)

318. Shindo S., Fujii F., Shirakawa M., Uchida K., Enomoto Y., Iwama T., Kawasaki M., Ando Y., Yoshimura S.
Morphologic features of carotid plaque rupture assessed by optical coherence tomography
AJNR Am J Neuroradiol, 36, 2140-2146 (2015)

319. Masuda T., Ueda M., Ueyama H., Shimada S., Ishizaki M., Imamura S., Yamamoto T., Ando Y. Megalencephalic leukoencephalopathy with subcortical cysts caused by compound heterozygous mutations in MLC1, in patients with and without subcortical cysts in the brain
J Neurol Sci, 351, 211-213 (2015)

320. Ueda A., Ueda M., Nagatoshi A., Hirano T., Ito T., Arai N., Uyama E., Mori K., Nakamura M., Shinriki S., Ikeda K., Ando Y.
Genotypic and phenotypic spectrum of CADASIL in Japan: the experience at a referral center in Kumamoto University from 1997 to 2014
J Neurol, 262, 1828-1836 (2015)

321. Hori H., Maeda Y., Ishizaki M., Hirahara T., Watanabe M., Yamashita S., Yamashita T., Uchino M., Ando Y.
A carrier with de novo mutation in the dystrophin gene whose myopathic symptoms became seriously progressive after pregnancy and delivery
Muscle Nerve, 52, 913-914 (2015)

322. Iryo Y., Hirai T., Nakamura M., Inoue Y., Watanabe M., Ando Y., Azuma M., Nishimura S., Shigematsu Y., Kitajima M., Yamashita Y.
Collateral circulation via the circle of Willis in patients with carotid artery steno-occlusive disease: evaluation on 3-T 4D MRA using arterial spin labelling
Clin Radiol, 70, 960-965, (2015)

323. Inoue Y., Honda S., Watanabe M., Ando Y.
Educational campaigns at point of purchase in rural supermarkets improve stroke knowledge
J Stroke Cerebrovasc Dis, 24, 480-484 (2015)

324. Yamashita S., Mori A., Nishida Y., Kurisaki R., Tawara N., Nishikami T., Misumi Y., Ueyama H., Imamura S., Higuchi Y., Hashiguchi A., Higuchi I., Morishita S., Yoshimura J., Uchino M., Takashima H., Tsuji S., Ando Y.
Clinicopathological features of the first Asian family having vocal cord and pharyngeal weakness with distal myopathy due to a MATR3 mutation
Neuropathol Appl Neurobiol, 41, 391-398 (2015)

325. Ohmori H., Hara A., Ishikawa K., Mizusawa H., Ando Y.
Clinical characteristics of combined cases of spinocerebellar ataxia types 6 and 31
J Neurogenet, 29, 80-84 (2015)

326. Kon T., Misumi Y., Nishijima H., Honda M., Suzuki C., Baba M., Inomata Y., Obayashi K., Ando Y., Tomiyama M.
Effects of liver transplantation and tafamidis in hereditary transthyretin amyloidosis caused by transthyretin Leu55Pro mutation: a case report
Amyloid, 22, 203-204 (2015)

327. Kitagawa K., Misumi Y., Ueda M., Hayashi Y., Tasaki M., Obayashi K., Yamashita T., Jono H., Arima H., Ando Y.
Inhibition of insulin amyloid fibril formation by cyclodextrins
Amyloid, 22, 181-186 (2015)

328. Yamashita S., Ando Y.
Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis
Transl Neurodegener, 4, 13 (2015)

329. Hassan WA., Udaka N., Ueda A., Ando Y., Ito T.
Neoplastic lesions in CADASIL syndrome: report of an autopsied Japanese case
Int J Clin Exp Pathol, 8, 7533-7539 (2015)

330. Yokoyama T., Ueda M., Ando Y., Mizuguchi M.
Discovery of γ-mangostin as an amyloidogenesis inhibitor
Sci Rep, 5, 13570 (2015)

331. Shinoda K., Taki H., Obayashi K., Ando Y., Watanabe A., Komiya A., Fuse H., Tsuneyama K., Tobe K.
Wild-type ATTR amyloidosis of the ureter in a 56-year-old woman with rheumatoid arthritis and Sjögren's syndrome
Int J Clin Exp Pathol, 8, 8624-8627 (2015)

332. Nakama T., Yamashita S., Hirahara T., Okamoto S., Honda S., Watanabe M., Kimura E., Uchino M., Yano S., Kuratsu JI., Ando Y.
Usefulness of intraventricular infusion of antifungal drugs through Ommaya reservoirs for cryptococcal meningitis treatment
J Neurol Sci, 15, 259-262 (2015)

333. Uchida Y., Takada K., Tsugu Y., Ueda M., Yamashita T., Ando Y., Kobayashi S., Koike H., Watanabe T., Matsumoto T., Toyoda T., Yamada G., Matsukawa N.
Two brothers homozygous for the TTR V30M both presenting with a phenotype dominated by central nervous complications
Amyloid, 22, 261-262 (2015)

334. Ishizaki M., Fujimoto A., Ueyama H., Nishida Y., Imamura S., Uchino M., Ando Y.
Life-threatening arrhythmias in a becker muscular dystrophy family due to the duplication of exons 3-4 of the dystrophin gene
Intern Med, 54, 3075-3078 (2015)

335. Tasaki M., Ueda M., Obayashi K., Motokawa H., Kinoshita Y., Suenaga G., Yanagisawa A., Toyoshima R., Misumi Y., Masuda T., Yamashita T., Ando Y.
Rapid detection of wild-type and mutated transthyretins
Ann Clin Biochem, 53, 508-510 (2016)

336. Masuda T., Obayashi K., Ueda M., Fujimoto A., Tasaki M., Misumi Y., Ueda A., Nakane T., Yamashita T., Ando Y.
Therapeutic effects and prevention of recurrence of acquired idiopathic generalized anhidrosis via i.v. immunoglobulin treatment
J Dermatol, 43, 336-337 (2016)

337. Misumi Y., Narita Y., Oshima T., Ueda M., Yamashita T., Tasaki M., Obayashi K., Isono K., Inomata Y., Ando Y.
Recipient aging accelerates acquired transthyretin amyloidosis after domino liver transplantation
Liver Transpl, 22, 656-664 (2016)

338. Yanagisawa A., Ueda M., Sueyoshi T., Nakamura E., Tasaki M., Suenaga G., Motokawa H., Toyoshima R., Kinoshita Y., Misumi Y., Yamashita T., Sakaguchi M., Westermark P., Mizuta H., Ando Y.
Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid
Amyloid, 23, 26-32 (2016)

339. Shindo S., Fujii K., Shirakawa M., Uchida K., Sugiura Y., Saito S., Ando Y., Yoshimura S.
Three-dimensional optical frequency domain imaging evaluation of novel dual-layered carotid stent implantation for vulnerable carotid plaque
J Stroke Cerebrovasc Dis, 25, e31-32 (2016)

340. Obayashi K., Ando Y., Araki E.
Kukidome D., Nishikawa T., Sato M., Igata M., Kawashima J., Shimoda S., Matsui K., Measurement of small fibre pain threshold values for the early detection of diabetic polyneuropathy
Diabet Med, 33, 62-69 (2016)

341. Suzuki T., Kusumoto S., Yamashita T., Masuda A., Kinoshita S., Yoshida T., Takami-Mori F., Takino H., Ito A., Ri M., Ishida T., Komatsu H., Ueda M., Ando Y., Inagaki H., Iida S.
Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis
Ann Hematol, 95, 279-285 (2016)

342. Okumura K., Yamashita T., Masuda T., Misumi Y., Ueda A., Ueda M., Obayashi K., Jono H., Yamashita S., Inomata Y., Ando Y.
Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with
polyneuropathy after liver transplantation.
Amyloid, 23, 39-45 (2016)

343. Shimazaki C., Fuchida S., Suzuki K., Ishida T., Imai H., Sawamura M., Takamatsu H., Abe M., Miyamoto T., Hata H., Yamada M., Ando Y.
Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis
Int J Hematol, 103, 79-85 (2016)

344. Kawano H., Levi C., Inatomi Y., Pagram H., Kerr E., Bivard A., Spratt N., Miteff F., Yonehara T., Ando Y., Parsons M.
Internaitonal benchmarking for acute thrombolytic therapy implementation in Australia and Japan
J Clin Neurosci, 29, 87-91 (2016)
345. Ando Y., Sekijima Y., Obayashi K., Yamashita T., Ueda M., Misumi Y., Morita H., Machii K., Ohta M., Takata A., Ikeda S., Effects of tafamidis treatment on transthyretin(TTR) stabilization, efficacy, and safety in Japanese patients with familial amyoid polyneuropathy(TTR-FAP) with Val30Met and non-Varl30Met:A phase III, open-label study
J Neurol Sci, 15, 266-271 (2016)

346. Merlini G., Lousada I., Ando Y., Dispenzieri A., Gertz MA., Grogan M., Maurer MS., Sanchorawala V., Wechalekar A., Palladini G., Comenzo RL.
Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis.
Leukemia, 30(10):1979-1986 (2016)
347. Yoshimura Y., Kuwabara T., Shiraishi N., Kakizoe Y., Tasaki M., Obayashi K., Ando Y., Mukoyama M.
Transthyretin-related familial amyloidotic polyneuropathy found with abnormal urinalysis at a
general health checkup.
Nephrology (Carlton), 21, 341-342 (2016)

348. Asakura K., Yanai S., Nakamura S., Kawaski1 K., Eizuka M., Ishida K., Sugai T., Ueda M., Yamashita T., Ando Y., Matsumoto T.
Endoscopic findings of small-bowel lesions in familial amyloid polyneuropathy: A case report.
Medicine (Baltimore), 95, e2896 (2016)

352. Ando Y., Oku T., Tsuji T.
Platelet supernatant suppresses LPS-Induced nitric oxide production from macrophages accompanied by inhibition of NF-kB signaling and increased arginase-1 expression
PLoS One, 11, e0162208 (2016)

353. Jono H., Su Y., Obayashi K., Tanaka Y., Ishiguro A., Nishimura H., Shinriki S., Ueda M., Ikeda K., Yamagata K., Ichihara K., Ando Y., Scientific Committee for the Asia-Pacific Federation of Clinical Biochemistry.
Sources of variation of transthyretin in healthy subjects in east and southeast asia: Clinical and experimental evidence for the effect of alcohol on transthyretin metabolism
Clin Chim Acta, 458, 5-11 (2016)

354. Kimura T., Fukushima S., Miyashita A., Aoi J., Jinnin M., Kosaka T., Ando Y., Matsukawa M., Inoue H., Kiyotani K., Park JH., Nakamura Y., Ihn H.
Myasthenic crisis and polymyositis induced by one dose of nivolumab
Cancer Sci, 107, 1055-1058 (2016)

355. Kikukawa Y., Hata H., Ueda M., Yamashita T., Nasu S., Ide K., Ueno S., Ando Y., Mitsuya H., Okuno Y.
Successful treatment of amyloid light-chain amyloidosis in a charcot-marie-tooth disease patient with lenalidomide, cyclophosphamide, and dexamethasone
Intern Med, 55, 2707-2712 (2016)

356. Yamashita T., Ueda M., Saga N., Nanto K., Tasaki M., Masuda T., Misumi Y., Oda S., Fujimoto A., Amano T., Takamatsu K., Yamashita S., Obayashi K., Matsui H., Ando Y.
Hereditary amyloidosis with cardiomyopathy caused by the novel variant transthyretin A36D
Amyloid, 23, 207-208 (2016)

357. Mori Y., Yamashita S., Kato M., Masuda T., Takamatsu K., Kumamoto T., Sasaki R., Ando Y.
Thomsen disease with ptosis and abnormal MR findings
Neuromuscul Disord, 26, 805-808 (2016)

358. Suenaga G., Ikeda T., Komohara Y., Takamatsu K., Kakuma T., Tasaki M., Misumi Y., Ueda M., Ito T., Senju S., Ando Y.
Involvement of macrophages in the pathogenesis of familial amyloid polyneuropathy and efficacy of human iPS cell-derived macrophages in its treatment
PLoS One, 11, e0163944 (2016)

359. Ando T., Goto Y., Mano K., Ueda A., Ando Y., Mizuta I., Mizuno T.
CADASIL presenting as acute bilateral multiple subcortical infarcts without a characteristic temporal pole or any external capsule lesions
Intern Med, 55, 2873-2876 (2016)

360. Hosoi A., Su Y., Torikai M., Jono H., Ishikawa D., Soejima K., Higuchi H., Guo J., Ueda M., Suenaga G., Motokawa H., Ikeda T., Senju S., Nakashima T., Ando Y.
Novel antibody for the treatment of transthyretin amyloidosis
J Biol Chem, 25, 25096-25105 (2016)

361. Koike H., Ikeda S., Takahashi M., Kawagashira Y., Iijima M., Misumi Y., Ando Y., Ikeda SI., Katsuno M., Sobue G.
Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy
Neurology, 87, 2220-2229 (2016)

362. Kawano H., Levi C., Inatomi Y., Pagram H., Kerr E., Bivard A., Spratt N., Miteff F., Yonehara T., Ando Y., Parsons M.
International benchmarking for acute thrombolytic therapy implementation in Australia and Japan.
J Clin Neurosci, 29, 87-91 (2016)

363. Fukasawa K., Higashimoto Y., Motomiya Y., Uji Y., Ando Y.
Influence of heparin molecular size on the induction of C- terminal unfolding in β2-microglobulin
Mol Biol Res Commun, 5, 225-232 (2016)
364. Nakane S., Mukaino A., Maeda Y., Higuchi O., Matsuo H., Ando Y.
Extra-autonomic manifestations in autoimmune autonomic ganglionopathy: a Japanese survey
J Neurol Neurosurg Psychiatry, 88, 367-368 (2017)

367. Nishi S., Muso E., Shimizu A., Sugiyama H., Yokoyama H., Ando Y., Goto S., Fujii H.
A clinical evaluation of renal amyloidosis in the Japan renal biopsy registry: a cross-sectional study
Clin Exp Nephrol, 21, 624-632 (2017)

368. Inatomi Y., Nakajima M., Yonehara T., Ando Y. Ipsilateral hemiparesis in ischemic stroke patients Acta Neurol Scand, 136: 31-40, (2017)

369. Ishizaki M., Kedoin C., Ueyama H., Maeda Y., Yamashita S., Ando Y.
Utility of skinfold thickness measurement in non-ambulatory patients with Duchenne muscular dystrophy
Neuromuscul Disord, 27, 24-28 (2017)

370. Kasagi T., Nobata H., Suzuki K., Miura N., Banno S., Takami A., Yamashita T., Ando Y., Imai H.
Light chain deposition disease diagnosed with laser micro-dissection, liquid chromatography, and tandem mass spectrometry of nodular glomerular lesions
Intern Med, 56, 61-66 (2017)

371. Nakahara K., Nakane S., Nakajima M., Yamashita S., Mori T., Ando Y.
Effect of thymectomy for thymic atrophy in myasthenia gravis:A retrospective study on 93 patients
J Neuroimmunol. 305, 182-185 (2017)

372. Huang G., Ueda M., Tasaki M., Yamashita T., Misumi Y., Masuda T., Suenaga G., Inoue Y., Kinoshita Y., Matsumoto S., Mizukami M., Tsuda Y., Nomura T., Obayashi K., Ando Y.
Clinicopathological and biochemical findings of thyroid amyloid in hereditary transthyretin amyloidosis with and without liver transplantation
Amyloid., 24, 24-29 (2017)

373. Yamamoto F., Yamashita S., Kawano H., Tanigawa T., Mihara Y., Gonoi T., Ando Y.
Meningitis and ventriculitis due to nocardia araoensis infection
Intern Med, 56, 853-859 (2017)

374. Oda S., Utsunomiya D., Nakaura T., Yuki H., Kidoh M., Morita K., Takashio S., Yamamuro M., Izumiya Y., Hirakawa K., Ishida T., Tsujita K., Ueda M., Yamashita T., Ando Y., Hata H., Yamashita Y.
Identification and assessment of cardiac amyloidosis by myocardial strain analysis of cardiac magnetic resonance imaging
Circ J, 81, 1014-1021 (2017)

375. Inatomi Y., Nakajima M., Yonehara T., Ando Y.
Ipsilateral tremor-like grasp reaction in a patient with ischemic stroke
Cogn Behav Neurol, 30, 37-41 (2017)

376. Singu T., Inatomi Y., Yonehara T., Ando Y.
Calcified amorphous tumor causing shower embolism to the brain: A case report with serial echocardiographic and neuroradiologic images and a review of the literature
J Stroke Cerebrovasc Dis, 26, e85-e89 (2017)

377. Tawara N., Yamashita S., Zhang X., Korogi M., Zhang Z., Doki T., Matsuo Y., Nakane S.,
Maeda Y., Sugie K., Suzuki N., Aoki M., Ando Y.
Pathomechanisms of anti-cytosolic 5'-nucleotidase 1A autoantibodies in sporadic inclusion body myositis
Ann Neurol, 81, 512-525 (2017)

378. Misumi Y., Ueda M., Yamashita T., Masuda T., Kinoshita Y., Tasaki M., Nagase T., Ando Y.
Novel screening for transthyretin amyloidosis by using fat ultrasonography
Ann Neurol, 81, 604-608 (2017)

379. Inatomi Y., Nakajima M., Yonehara T., Ando Y.
Clinical characteristics of patients seizure following the 2016 Kumamoto earthquake
.J Clin Neurosci, 40, 123-129 (2017)

380. Mukaino A., Nagaoka A., Yoshimura S., Nakajima H., Shiraishi H., Motomura M., Morikawa M., Kusunoki S., Nakane S., Ando Y., Tsujino A: Modified method of intravenous immunoglobulin administration for patients with intractable multifocal motor neuropathy: A case report Clinical and Experimental Neuroimmunology, 2: 141-145 (2017)

381. Miura M., Nakajima M., Fujimoto A., Kaku Y., Kawano T., Watanabe M., Kuratsu JI., Ando Y.
High prevalence of small vessel disease long after cranial irradiation
J Clin Neurosci, 46, 129-135 (2017)

382. Ikenoshita S., Yamashita S., Sakamoto T., Misumi Y., Ando Y.
Hemiatrophy of the tongue with contralateral hemiparesis in a patient with multifocal acquired demyelinating sensory and motor neuropathy
J Clin Neurol, 13, 422-423 (2017)

383. Singu T., Inatomi Y., Yonehara T., Ando Y
Delayed leukoencephalopathy after recanalized cardioembolic stroke: Two case reports
J Neurol Sci, 379, 81-83 (2017)

384. Nagatoshi A., Ueda M., Ueda A., Tasaki M., Inoue Y., Ma Y., Masuda T., Mizukami M., Matsumoto S., Kosaka T., Kawano T., Ito T., Ando Y.
Serum amyloid P component: A novel potential player in vessel degeneration in CADASIL
J Neurol Sci, 379, 69-76 (2017)

385. Maeda Y., Yonemochi Y., Nakajyo Y., Hidaka H., Ikeda T., Ando Y.
CXCL12 and osteopontin from bone marrow-derived mesenchymal stromal cells improve muscle regeneration
Sci Rep, 7, 3305 (2017)

386. Nishi S., Hoshino J., Yamamoto S., Goto S., Fuji H., Ubara Y., Motomiya Y., Morita H., Takaichi K., Yamagata K., Shigematsu T., Ueda M., Ando Y.
A multicenter cross sectional study for bone-articular lesions associated with dialysis related amyloidosis in Japan
Nephrology, 23, 640-645 (2017)

387. Masuda T., Ueda M., Suenaga G., Misumi Y., Tasaki M., Izaki A., Yanagisawa Y., Inoue Y., Motokawa H., Matsumoto S., Mizukami M., Arimura A., Deguchi T., Nishio Y., Yamashita T., Inomata Y., Obayashi K., Ando Y.
Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy
Neurology, 88, 2192-2197 (2017)

388. Suenaga G., Ikeda T., Masuda T., Motokawa H., Yamashita T., Takamatsu K., Misumi Y., Ueda M., Matsui H., Senju S., Ando Y.
Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin
Sci Rep, 7, 1579 (2017)

389. Inoue Y., Ueda M., Tasaki M., Takeshima A., Nagatoshi A., Masuda T., Misumi Y., Kosaka T., Nomura T., Mizukami M., Matsumoto S., Yamashita T., Takahashi H., Kakita A., Ando Y.
Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy
Acta Neuropathol, 134, 605-617 (2017)

390. Oda S., Utsunomiya D., Morita K., Nakaura T., Yuki H., Kidoh M., Hirata K., Taguchi N., Tsuda N., Shiraishi S., Namimoto T., Hirakawa K., Takashio S., Izumiya Y., Yamamuro M., Hokimoto S., Tsujita K., Ueda M., Yamashita T., Ando Y., Yamashita Y.
Cardiovascular magnetic resonance myocardial T1 mapping to detect and quantify cardiac involvement in familial amyloid polyneuropathy
Eur Radiol, 27, 4631-4638 (2017)

391. Matsumoto S., Ueda M., Yamashita T., Amano T., Misumi Y., Tasaki M., Masuda T., Mizukami M., Furuya H., Ando Y.
A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation
Amyloid, 24, 97-98 (2017)

392. Tasaki M., Ueda M., Obayashi K., Kinoshita Y., Matsumoto S., Mizukami M., Masuda T., Misumi Y., Yamashita T., Ando Y.
Identification of amyloid precursor protein from autopsy and biopsy specimens using LMD-LC-MS/MS: the experience at Kumamoto University
Amyloid, 24, 167-168 (2017)

393. Izaki A., Obayashi K., Suenaga G., Ueda M., Yamashita T., Tasaki M., Yanagisawa Y., Masuda T., Misumi Y., Ando Y.
In vitro and in vivo assessment of novel derivatives for detecting various amyloid deposits
Amyloid, 24, 17 (2017)

394. Nomura T., Yamashita T., Misumi Y., Ueda M., Masuda T., Tasaki M., Ando Y.
A case with a novel variant transthyretin A36D presenting cardiac phenotype
Amyloid, 24, 100 (2017)

395. Tsuda Y., Misumi Y., Ueda M., Tasaki M., Huang G., Masuda T., Suenaga G., Kinoshita Y., Obayashi K., Yamashita T., Ando Y.
Iatrogenic systemic transthyretin amyloid deposits in a case with domino liver transplantation: an autopsy case study
Amyloid, 24, 125 (2017)

396. Ando Y., Ueda M.
Antibody therapy for transthyretin-related hereditary amyloid polyneuropathy: another therapeutic option
Amyloid, 24, 113-114 (2017)

397. Obayashi K., Ueda M., Yamashita T., Tasaki M., Izaki A., Yanagisawa Y., Masuda T., Misumi Y., Ando Y.
Long-term effects of liver transplantation on small-fiber dysfunction in Japanese transthyretin (ATTR) V30M hereditary amyloidosis with polyneuropathy (FAP)
Amyloid, 24, 99 (2017)

398. Watanabe T., Obayashi K., Misumi Y., Tasaki M., Shinriki S., Ando T., Akagami T., Ueda M., Yamashita T., Hirotani S., Ando Y.
Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg
Amyloid, 24, 119 (2017)

399. Koike H., Ikeda S., Takahashi M., Kawagashira Y., Iijima M., Misumi Y., Ando Y., Ikeda SI., Katsuno M., Sobue G.
Disruption of blood-nerve barriers in hereditary transthyretin (ATTR) amyloidosis
Amyloid, 24, 89-90 (2017)

400. Mizukami M., Ueda M., Tasaki M., Misumi Y., Masuda T., Matsumoto S., Yamashita T., Ando Y.
Clinicopathological and biochemical findings of late-onset hereditary transthyretin amyloidosis 16 years after liver transplantation: an autopsy case study
Amyloid, 24, 122 (2017)

401. Misumi Y., Oshima T., Ueda M., Yamashita T., Tasaki M., Masuda T., Obayashi K., Ando Y.
Occurrence factors and clinical picture of iatrogenic transthyretin amyloidosis after domino liver transplantation
Amyloid, 24, 123-124 (2017)

402. Yanagisawa Y., Obayashi K., Tasaki M., Izaki A., Masuda T., Misumi Y., Ueda M., Yamashita T, Ando Y.
Clinicopathological characteristics of a patient with ureteral amyloidosis
Amyloid, 24, 101 (2017)

403. Yamashita T., Ueda M., Tasaki M., Masuda T., Misumi Y., Takamatsu K., Obayashi K., Ando Y
Establishment of a diagnostic center for amyloidosis in Japan by Kumamoto University
Amyloid, 24, 169-170 (2017)

404. Miura M., Nakajima M., Fujimoto A., Shiraishi S., Liebeskind DS., Ando Y.
Decreased Signal Intensity Ratio on MRA Reflects Misery Perfusion on SPECT in Patients with Intracranial Stenosis
J Neuroimaging. 28, 206-211 (2017)

405. Tsuda N., Shiraishi S., Oda S., Ogasawara K., Sakamoto F., Tomiguchi S., Fujisue K., Takashio S., Izumiya Y., Tsujita K., Ando Y., Yamashita Y.
Utility of single-photon emission computed tomography/computed tomography fusion imaging with 99 mTc-Pyrophosphate scintigraphy in the assessment of cardiac transthyretin amyloidosis
Circ J, 82, 1970-1971 (2017)

406. Inatomi Y., Nakajima M., Yonehara T., Ando Y.
407. Successful Switching of Anticoagulants in a Patient with Superficial Siderosis and Atrial Fibrillation
Neurol Clin Neurosci, 5: 36-38 (2017)

408. Singu T., Inatomi Y., Yonehara T., Ando Y.
Calcified amorphous tumor causing shower embolism to the brain: a case report with serial echocardiographic and neuro-radiologic images and review of the literatures
J Stroke Cerebrovasc Dis, 25: 85-89 (2017)

409. Yamashita S., Tawara N., Ando Y.
Anti-NT5C1A autoantibodies for the diagnosis and study of the pathogenesis of sporadic inclusion body myositis
Clin Exp Neuroimmunol, 8:292-301 (2017)

410. Okada M., Misumi Y., Ueda M., Yamashita T., Masuda T., Tasaki M., Ando Y.
A novel transthyretin variant V28S (p.V48S) with a double-nucleotide substitution in the same codon
Amyloid, 24, 231-232 (2017)

411. Inatomi Y., Nakajima M., Yonehara T., Ando Y.
Clinical characteristics of patients with ischemic stroke following the 2016 Kumamoto earthquake
J Clin Neurosci, 46, 79-84 (2017)


412. Matsubara S, Koga M, Ohara T, Iguchi Y, Minatoya K, Tahara Y, Fukuda T, Miyazaki Y, Kajimoto K, Sakamoto Y, Makita N, Tokuda N, Nagatsuka K, Ando Y, Toyoda K.
Cerebrovascular imaging of cerebral ischemia in acute type A aortic dissection
J Neurol Sci, 388: 23-27 (2018)

413. Nagao Y., Nakajima M., Hirahara T., Wada K., Terasaki T., Nagamine M., Ando Y.
Calcified cerebral embolism due to a calcified amorphous tumor
J Stroke Cerebrovasc Dis, 27: 115-116 (2018)

414. Shimazaki C., Hata H., Iida S., Ueda M., Katoh N., Sekishima Y., Ikeda S., Yazaki M., Fukushima W., Ando Y.
Nationwide survey of 741 patients with systemic amyloid light-chain amyloidosis in Japan
Intern Med, 57, 181-187 (2018)

415. Yamashita T., Ueda M., Misumi Y., Masuda T., Nomura T., Tasaki M., Takamatsu K., Sasada K, Obayashi K., Matsui H., Ando Y.
Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan
J Neurol, 265, 134-140 (2018)

416. Sekijima Y., Yazaki M., Ueda M., Koike H., Yamada M., Ando Y.
First nationwide survey on systemic wild-type ATTR amyloidosis in Japan
Amyloid, 25, 8-10 (2018)

417. Shinriki S., Jono H., Maeshiro M., Nakamura T., Guo J., Li JD., Ueda M., Yoshida R., Shinohara M, Nakayama H., Matsui H., Ando Y.
Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.
J Pathol, 244, 367-379 (2018)

418. Oda S., Nakaura T., Utsunomiya D., Hirakawa K., Takashio S., Izumiya Y., Tsujita K., Hata H., Ando Y., Yamashita Y.
Late iodine enhancement and myocardial extracellular volume quantification in cardiac amyloidosis by using dual-energy cardiac computed tomography performed on a dual-layer spectral detector scanner.
Amyloid, 25, 137-138 (2018)

419. Ikeda T., Masuda T., Ueda M., Yamashita T., Misumi Y., Shinriki S., Ando Y.
Unwanted road to anaemia in transthyretin familial amyloid polyneuropathy may continue irrespective of tafamidis treatment.
Ann Clin Biochem, 55, 571-575 (2018)

420. Nakane S., Ando Y., Matsuo H.
Yips preceding baseball-related dystonia.
Parkinsonism Relat Disord, 50, 128-129 (2018)

421. Tawara N., Yamashita S., Kawakami K., Kurashige T., Zhang Z., Tasaki M., Yamamoto Y., Nishikami T., Doki T., Zhang X., Matsuo Y., Kimura E., Tawara A., Maeda Y., Hauschka SD., Maruyama H., Ando Y.
Muscle-dominant wild-type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43-positive inclusions.
Exp Neurol, 309, 169-180 (2018)

422. Okuda Y., Yamada T., Ueda M., Ando Y.
First nationwide survey of 199 patients with amyloid amyloidosis in Japan
Intern Med, 57, 3351-3355 (2018)

423. Fukuda M., Yoshizawa T., Karim MF., Sobuz SU., Korogi W., Kobayasi D., Okanishi H., Tasaki M., Ono K., Sawa T., Sato Y., Chirifu M., Masuda T., Nakamura T., Tanoue H., Nakashima K., Kobashigawa Y., Morioka H., Bober E., Ohtsuki S., Yamagata Y., Ando Y., Oike Y., Araki N., Takeda S., Mizuta H., Yamagata K.
SIRT7 has a critical role in bone formation by regulating lysine acylation of SP7/Osterix.
Nat Commun, 9, 2833 (2018)

424. Shiotsu H., Okada K., Shibuta T., Kobayashi Y., Shirahama S., Kuroki C., Ueda S., Ohkuma M., Ikeda K., Ando Y., Matsui H., Kayamori Y., Umemura T.
The influence of pre-analytical factors on the analysis of circulating microRNA
Microma, 195-203 (2018)

425. Okada M., Yamashita S., Ueyama H., Ishizaki M., Maeda Y., Ando Y.
Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis
NeurologicalSci, 11, 11-14 (2018)

426. Nakano Y., Tadokoro K., Ohta Y., Sato K., Takemoto M., Hishikawa N., Yamashita T., Ando Y., Abe K.
Two cases of late onset familial amyloid polyneuropathy with a Glu61Lys transthyretin variant
J Neurol Sci, 390, 22-25 (2018)

427. Watari M., Nakane S., Mukaino A., Nakajima M., Mori Y., Maeda Y., Masuda T.,Takamatsu K., Kouzaki Y., Higuchi O., Matsuo H., Ando Y.
Autoimmune postural orthostatic tachycardia syndrome
Ann Clin Transl Neurol, 5, 486-492 (2018)

428. Naganuma M., Inatomi Y., Nakajima M., Ohta T., Yonehara T., Ando Y.
Is the Occlusion Site of the Lenticulostriate Artery Identified on Admission Related to Clinical Prognosis in Patients with Lacunar Stroke?
J Stroke Cerebrovasc Dis. 27, 2035-2042 (2018)

429. Naganuma M., Inatomi Y., Nakajima M., Yonehara T., Ando Y.
Associations between Uric Acid level and 3-month functional outcome in acute ischemic stroke patients treated with/without edaravone
Cerebrovasc Dis, 45, 115-123 (2018)

430. Hayashi Y., Higashi T., Motoyama K., Jono H., Ando Y., Arima H.
In vitro and in vivo siRNA delivery to hepatocyte utilizing ternary complexation of lactosylated dendrimer/cyclodextrin conjugates, siRNA and low-molecular-weight sacran
Int J Biol Macromol, 107, 1113-1121 (2018)

431. Fukasawa K., Higashimoto Y., Ando Y., Motomiya Y.
Selection of DNA aptamer that blocks the fibrillogenesis of a proteolytic amyloidogenic fragment of β2 m
Ther Apher Dial, 22, 61-66 (2018)

432. Nishi S., Hoshino J., Yamamoto S., Goto S., Fujii H., Ubara Y., Motomiya Y., Morita H., Takaichi K., Yamagata K., Shigematsu T., Ueda M., Ando Y.
Multicentre cross-sectional study for bone-articular lesions associated with dialysis related amyloidosis in Japan.
Nephrology (Carlton), 23, 640-645 (2018)

433. Takashio S., Yamamuro M., Izumiya Y., Hirakawa K., Marume K., Yamamoto M., Ueda M., Yamashita T., Ishibashi-Ueda H., Yasuda S., Ogawa H., Ando Y., Anzai T., Tsujita K.
Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis
ESC Heart Fail, 5, 27-35 (2018)

434. Yamashita S., Nakama T., Ueda M., Honda S., Kimura E., Konagaya M., Ando Y.
Tongue strength in patients with subacute myelo-optico-neuropathy
J Clin Neurosci, 47, 84-88 (2018)

435. Ueda M., Yamashita T., Misumi Y., Masuda T., Ando Y.
Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
Amyloid, 25, 143-147 (2018)

436. Takamatsu K., Nakane S., Suzuki S., Kosaka T., Fukushima S., Kimura T., Miyashita A., Mukaino A., Yamakawa S., Watanabe K., Jinnin M., Komohara Y., Ihn H., Ando Y.
Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia.
Ann Clin Transl Neurol, 5, 1421-1427 (2018)

437. Hamanaka K., Miyatake S., Koshimizu E., Tsurusaki Y., Mitsuhashi S., Iwama K., Alkanaq AN., Fujita A., Imagawa E., Uchiyama Y., Tawara N., Ando Y., Misumi Y., Okubo M., Nakashima M., Mizuguchi T., Takata A., Miyake N., Saitsu H., Iida A., Nishino I., Matsumoto N.
RNA sequencing solved the most common but unrecognized NEB pathogenic variant in Japanese nemaline myopathy.
Genet Med, 2018 in press.

438. Ikeda T., Kakuma T., Watari M., Ando Y.
Fingolimod-induced decrease in heart rate may predict subsequent decreasing degree of lymphocytes.
Sci Rep, 8, 16430 (2018)

439. Masuda T., Ueda M., Kitajima M., Morita K., Misumi Y., Yamashita T., Obayashi K., Yamashita Y., Ando Y.
Teaching NeuroImages: Morphology of lumbosacral dorsal root ganglia and plexus in hereditary transthyretin amyloidosis
Neurology, 91, e1834-e1835 (2018)

440. Kumai Y., Miyamoto T., Matsubara K., Samejima Y., Yamashita S., Ando Y., Orita Y.
Assessment of oropharyngeal swallowing dysfunction in myasthenia gravis patients presenting with difficulty in swallowing.
Auris Nasus Larynx, 2018 in press.

441. Nakane S., Mukaino A., Higuchi O., Watari M., Maeda Y., Yamakawa M., Nakahara K., Takamatsu K., Matsuo H., Ando Y.
Autoimmune autonomic ganglionopathy: an update on diagnosis and treatment.
Expert Rev Neurother, 18, 953-965 (2018)

442. Mukaino A., Tsuda M., Yamashita S., Kosaka T., Wada K., Ando Y.
Cerebrotendinous xanthomatosis presenting with extensive cerebral cortex symptoms: A case report.
Clin Neurol Neurosurg, 174, 217-219 (2018)

443. Mukai M., Mizuta I., Ueda A., Nakashima D., Kushimura Y., Noto YI., Ohara T., Itoh K., Ando Y., Mizuno T.
A Japanese CADASIL patient with homozygous NOTCH3 p.Arg544Cys mutation confirmed pathologically.
J Neurol Sci, 394, 38-40 (2018)


444. Miura M., Nakajima M., Fujimoto A., Shiraishi S., Liebeskind DS., Ando Y.
Decreased Signal Intensity Ratio on MRA Reflects Misery Perfusion on SPECT in Patients with Intracranial Stenosis.
J Neuroimaging, 28, 206-211 (2018)

445. Tsuda N., Shiraishi S., Oda S., Ogasawara K., Sakamoto F., Tomiguchi S., Fujisue K., Takashio S., Izumiya Y., Tsujita K., Ando Y., Yamashita Y.
Utility of Single-Photon Emission Computed Tomography/Computed Tomography Fusion Imaging With 99 mTc-Pyrophosphate Scintigraphy in the Assessment of Cardiac Transthyretin Amyloidosis
Circ J, 82, 1970-1971 (2018)


446. Tsuda Y., Yamanaka K., Toyoshima R., Ueda M., Masuda T., Misumi Y., Ogura T., Ando Y.
Development of transgenic Caenorhabditis elegans expressing human transthyretin as a model
for drug screening.
Sci Rep, 8, 17884 (2018)

447. Yamamoto H., Hashimoto T., Kawamura S., Hiroe M., Yamashita T., Ando Y., Yokochi T.
Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
J Med Case Rep, 12, 370 (2018)

448. Mizutani H., Nakane S., Ikeda T., Nakamura H., Takamatsu K., Makino K., Tawara N.,
Mukaino A., Watari M., Matsui H., Mukasa A., Ando Y.
CSF TACI and BAFF levels in patients with primary CNS lymphoma as novel diagnostic
biomarkers.
Ann Clin Transl Neurol, 5, 1611-1616 (2018)

449. Takeuchi Y., Nakahara K., Nakajima M., Inoue Y., Matsumura R., Yamaguchi M., Katabuchi
H., Ando Y.
A 23-Year-Old Woman with Sudden-Onset Blindness of the Right Eye.
J Stroke Cerebrovasc Dis, 28(4), e12-e13 (2019)

450. Kurisaki R., Ueyama H., Maeda Y., Sakamoto T., Nakahara K., Nakane S., Yamashita S., Ando Y; 2016 Kumamoto Earthquake PD Study Group.
Impact of major earthquakes on Parkinson's disease
J Clin Neurosci, 61, 130-135 (2019)

451. Kameyama H., Uchimura K., Yamashita T., Kuwabara K., Mizuguchi M., Hung SC., Okuhira K., Masuda T., Kosugi T., Ohgita T., Saito H., Ando Y., Nishitsuji K.
The Accumulation of Heparan Sulfate S-Domains in Kidney Transthyretin Deposits Accelerates Fibril Formation and Promotes Cytotoxicity.
Am J Pathol, 189, 308-319 (2019)

452. Kato TS., Ikeda N., Maurer MS., Ando Y., Tanno K.
Transthyretin Stabilizer Is Associated With Expanding Apical Sparing Area and Improving Global Cardiac Function in a Patient With Wild-Type Cardiac Amyloidosis.
Circ J, 83, 390 (2019)

453. Nakamura M., Misumi Y., Nomura T., Oka W., Isoguchi A., Kanenawa K., Masuda T.,
Yamashita T., Inoue Y., Ando Y., Ueda M.
Extreme Adhesion Activity of Amyloid Fibrils Induces Subcutaneous Insulin Resistance.
Diabetes, 68, 609-616 (2019)

454. Tasaki M., Ueda M., Hoshii Y., Mizukami M., Matsumoto S., Nakamura M., Yamashita T.,
Ueda A., Misumi Y., Masuda T., Inoue Y., Torikai T., Nomura T., Tsuda Y., Kanenawa K.,
Isoguchi A., Okada M., Matsui H., Obayashi K., Ando Y.
A novel age-related venous amyloidosis derived from EGF-containing fibulin-like
extracellular matrix protein 1.
J Pathol, 427, 444-455 (2019)

455. Hirakawa K., Takashio S., Marume K., Yamamoto M., Hanatani S., Yamamoto E., Sakamoto K., Izumiya Y., Kaikita K., Oda S., Utsunomiya D., Shiraishi S., Ueda M., Yamashita T., Yamashita Y., Ando Y., Tsujita K.
Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis.
ESC Heart Fail, 6, 122-130 (2019)

456. Endo Y., Hasegawa K., Nomura R., Arishima H., Kikuta KI., Yamashita T., Inoue Y., Ueda M., Ando Y., Wilson MR., Hamano T., Nakamoto Y., Naiki H.
Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy.
Acta Neuropathol Commun, 7, 12 (2019)


457. Kufukihara K, Watanabe Y, Inagaki T, Takamatsu K, Nakane S, Nakahara J, Ando Y, Suzuki S
Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and/or myocarditis.
Sci Rep, 9, 5284 (2019)

458. Inoue M, Ueda M, Higashi T, Anno T, Fujisawa K, Motoyama K, Mizuguchi M, Ando Y, Jono H, Arima H.
Therapeutic Potential of Polyamidoamine Dendrimer for Amyloidogenic Transthyretin Amyloidosis.
ACS Chem Neurosci, 2019 in press.

459. Miura M, Yoshimura S, Yamada K, Kanamaru T, Matsumoto K, Shindo S, Uchida K, Shirakawa M, Kawasaki M, Ando Y.
Presence of plaque neovascularization on optical frequency domain imaging predicts progression of carotid artery stenosis.
World Neurosurg, 2019 in press.

460. Doki T, Yamashita S, Wei FY, Hara K, Yamamoto T, Zhang Z, Zhang X, Tawara N, Hino H, Uyama E, Kurashige T, Maruyama H, Tomizawa K, Ando Y
Mitochondrial localization of PABPN1 in oculopharyngeal muscular dystrophy.
Lab Invest. 2019 in press.